View Filing Data

Issuance of Common Stock upon exercise of employee stock options

$ (115,014)

$ (135,294)

$ (115,014)

$ (87,990)

110

Equity based compensation expenses to employees and non-employee consultants

2,956

1,082

1,078

Conversion of convertible preferred stock into ordinary shares

140,915

131,208

Exercise of warrants into common stock, shares

$ 6,115

154,768

Change in comprehensive loss related to foreign currency translation adjustments

$ (161)

(35)

(32)

21,121

(21,378)

(28,180)

Series D-1 Preferred stock [Member]

166,944

(135,294)

(115,014)

Issuance of Convertible Preferred stock, net of issuance expenses

Series D-2 Preferred stock [Member]

Issuance of Convertible Preferred stock, net of issuance expenses

Issuance of Convertible Preferred stock, net of issuance expenses, shares

2,304,524

Series D-3 Preferred stock [Member]

Issuance of Convertible Preferred stock, net of issuance expenses

Series E Convertible Preferred stock [Member]

Issuance of Convertible Preferred stock, net of issuance expenses

Convertible Preferred stock [Member]

$ 100,229

$ 116,203

$ 100,229

$ 95,234

Issuance of Common Stock upon exercise of employee stock options

68,493,373

75,422,773

68,493,373

66,327,932

Issuance of Common Stock upon exercise of employee stock options, shares

Equity based compensation expenses to employees and non-employee consultants

Conversion of convertible preferred stock into ordinary shares

$ (140,915)

Conversion of convertible preferred stock into ordinary shares, shares

(84,743,792)

Number of shares of common stock sold to the public

Exercise of warrants into common stock, shares

Change in comprehensive loss related to foreign currency translation adjustments

$ 116,203

$ 100,229

Convertible Preferred stock [Member] | Series D-1 Preferred stock [Member]

75,422,773

68,493,373

Issuance of Convertible Preferred stock, net of issuance expenses

$ 4,995

Issuance of Convertible Preferred stock, net of issuance expenses, shares

2,165,441

Convertible Preferred stock [Member] | Series D-2 Preferred stock [Member]

Issuance of Convertible Preferred stock, net of issuance expenses

$ 5,983

Issuance of Convertible Preferred stock, net of issuance expenses, shares

2,598,528

Convertible Preferred stock [Member] | Series D-3 Preferred stock [Member]

Issuance of Convertible Preferred stock, net of issuance expenses

$ 9,991

Issuance of Convertible Preferred stock, net of issuance expenses, shares

4,330,872

Convertible Preferred stock [Member] | Series E Convertible Preferred stock [Member]

Issuance of Convertible Preferred stock, net of issuance expenses

$ 24,712

Issuance of Convertible Preferred stock, net of issuance expenses, shares

9,321,019

Receipt on account of Convertible Preferred stock [Member]

Issuance of Common Stock upon exercise of employee stock options

$ 5,314

Equity based compensation expenses to employees and non-employee consultants

5,314

Conversion of convertible preferred stock into ordinary shares

Change in comprehensive loss related to foreign currency translation adjustments

Receipt on account of Convertible Preferred stock [Member] | Series D-1 Preferred stock [Member]

5,314

Issuance of Convertible Preferred stock, net of issuance expenses

Receipt on account of Convertible Preferred stock [Member] | Series D-2 Preferred stock [Member]

Issuance of Convertible Preferred stock, net of issuance expenses

(5,314)

Receipt on account of Convertible Preferred stock [Member] | Series D-3 Preferred stock [Member]

Issuance of Convertible Preferred stock, net of issuance expenses

Receipt on account of Convertible Preferred stock [Member] | Series E Convertible Preferred stock [Member]

Issuance of Convertible Preferred stock, net of issuance expenses

Common stock [Member]

^[1]

Issuance of Common Stock upon exercise of employee stock options

2,782,491

2,809,950

2,782,491

2,718,381

^[1]

Issuance of Common Stock upon exercise of employee stock options, shares

34,898

27,459

64,110

Equity based compensation expenses to employees and non-employee consultants

Conversion of convertible preferred stock into ordinary shares

$ 3

Conversion of convertible preferred stock into ordinary shares, shares

28,247,923

Number of shares of common stock sold to the public

$ 1

8,050,000

Exercise of warrants into common stock, shares

^[1]

154,768

Change in comprehensive loss related to foreign currency translation adjustments

$ 4

^[1]

Common stock [Member] | Series D-1 Preferred stock [Member]

39,297,539

2,809,950

2,782,491

Issuance of Convertible Preferred stock, net of issuance expenses

Issuance of Convertible Preferred stock, net of issuance expenses, shares

Common stock [Member] | Series D-2 Preferred stock [Member]

Issuance of Convertible Preferred stock, net of issuance expenses

Issuance of Convertible Preferred stock, net of issuance expenses, shares

Common stock [Member] | Series D-3 Preferred stock [Member]

Issuance of Convertible Preferred stock, net of issuance expenses

Issuance of Convertible Preferred stock, net of issuance expenses, shares

Common stock [Member] | Series E Convertible Preferred stock [Member]

Issuance of Convertible Preferred stock, net of issuance expenses

Issuance of Convertible Preferred stock, net of issuance expenses, shares

Additional paid in Capital [Member]

Issuance of Common Stock upon exercise of employee stock options

$ 4,745

$ 5,878

$ 4,745

$ 3,557

110

Equity based compensation expenses to employees and non-employee consultants

2,956

1,082

1,078

Conversion of convertible preferred stock into ordinary shares

140,912

131,207

Change in comprehensive loss related to foreign currency translation adjustments

6,115

Additional paid in Capital [Member] | Series D-1 Preferred stock [Member]

287,152

5,878

4,745

Issuance of Convertible Preferred stock, net of issuance expenses

Additional paid in Capital [Member] | Series D-2 Preferred stock [Member]

Issuance of Convertible Preferred stock, net of issuance expenses

Additional paid in Capital [Member] | Series D-3 Preferred stock [Member]

Issuance of Convertible Preferred stock, net of issuance expenses

Additional paid in Capital [Member] | Series E Convertible Preferred stock [Member]

Issuance of Convertible Preferred stock, net of issuance expenses

Accumulated other comprehensive Income (loss) [Member]

Issuance of Common Stock upon exercise of employee stock options

(26)

(61)

(26)

Equity based compensation expenses to employees and non-employee consultants

Conversion of convertible preferred stock into ordinary shares

Change in comprehensive loss related to foreign currency translation adjustments

(161)

(35)

(32)

Accumulated other comprehensive Income (loss) [Member] | Series D-1 Preferred stock [Member]

(222)

(61)

(26)

Issuance of Convertible Preferred stock, net of issuance expenses

Accumulated other comprehensive Income (loss) [Member] | Series D-2 Preferred stock [Member]

Issuance of Convertible Preferred stock, net of issuance expenses

Accumulated other comprehensive Income (loss) [Member] | Series D-3 Preferred stock [Member]

Issuance of Convertible Preferred stock, net of issuance expenses

Accumulated other comprehensive Income (loss) [Member] | Series E Convertible Preferred stock [Member]

Issuance of Convertible Preferred stock, net of issuance expenses

Accumulated deficit [Member]

Issuance of Common Stock upon exercise of employee stock options

$ (119,733)

(141,111)

(119,733)

(91,553)

Equity based compensation expenses to employees and non-employee consultants

Conversion of convertible preferred stock into ordinary shares

Change in comprehensive loss related to foreign currency translation adjustments

21,121

(21,378)

(28,180)

Accumulated deficit [Member] | Series D-1 Preferred stock [Member]

(119,990)

(141,111)

(119,733)

Issuance of Convertible Preferred stock, net of issuance expenses

Accumulated deficit [Member] | Series D-2 Preferred stock [Member]

Issuance of Convertible Preferred stock, net of issuance expenses

Accumulated deficit [Member] | Series D-3 Preferred stock [Member]

Issuance of Convertible Preferred stock, net of issuance expenses

Accumulated deficit [Member] | Series E Convertible Preferred stock [Member]

Issuance of Convertible Preferred stock, net of issuance expenses

[1]	Represents an amount less than $1.

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIENCY (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
Issuance of common stock in initial public offering, issuance expenses	$ 13,692
Series D-2 Preferred stock [Member]
Issuance of Convertible Preferred stock, issuance expenses		$ 17
Series D-3 Preferred stock [Member]
Issuance of Convertible Preferred stock, issuance expenses		$ 9
Series D-1 Preferred stock [Member]
Issuance of Convertible Preferred stock, issuance expenses			$ 5
Series E Preferred stock [Member]
Issuance of Convertible Preferred stock, issuance expenses	$ 288

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
Cash flows from operating activities:
Net income (loss)	$ 21,121	$ (21,378)	$ (28,180)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation	2,253	1,978	1,842
Capital loss from disposal of property	104
Interest expenses related to short term bank loan		44	6
Stock-based compensation related to employees and non-employee consultants stock options	2,956	1,082	1,078
Financial expenses (income), net related to term loan	(992)	431	768
Remeasurement of warrants to purchase convertible preferred stock	5,350	(53)	40
Changes in assets and liabilities:
Inventories	(48,507)	(10,681)	(1,161)
Prepaid expenses and other accounts receivable	(19,563)	(7,409)	3,776
Trade receivables, net	(16,333)	(9,911)	(1,040)
Trade payables	41,111	19,441	(7,928)
Employees and payroll accruals	1,668	1,726	307
Warranty obligations	13,698	7,803	3,866
Deferred revenues	3,989	(500)	1,934
Accrued expenses and other accounts payable	2,530	(418)	1,585
Lease incentive obligation	2,669
Net cash provided by (used in) operating activities	12,054	(17,845)	(23,107)
Cash flows from investing activities:
Purchase of property and equipment	(11,765)	(2,990)	(1,539)
Increase in restricted cash	(2,038)	(156)	(1,085)
Increase in long-term lease deposit	(134)	(1)	(154)
Net cash used in investing activities	(13,937)	(3,147)	(2,778)
Cash flows from financing activities:
Proceeds from short term bank loan	23,000	21,813	17,880
Repayment of short term bank loan	(36,326)	(12,447)	(17,485)
Proceeds from term loan (net of $100 transaction fee)			9,900
Repayments of term loan	(5,919)	(2,401)	(969)
Deferred charges related to term loan			(69)
Proceeds from initial public offering, net	131,402
Receipts on account of Convertible Preferred stock			5,314
Proceeds from exercise of employees and non-employee consultants stock options	84	51	110
Net cash provided by financing activities	136,953	17,676	19,676
Increase (decrease) in cash and cash equivalents	135,070	(3,316)	(6,209)
Cash and cash equivalents at the beginning of the period	9,754	13,142	19,437
Effect of exchange rate differences on cash and cash equivalents	(74)	(72)	(86)
Cash and cash equivalents at the end of the period	144,750	9,754	13,142
Supplemental disclosure of non-cash financing activities:
Deferred issuance costs related to initial public offering	194
Cashless exercise of warrants to purchase common stock	6,115
Supplemental disclosure of cash flow information:
Cash paid for interest	896	1,085	1,065
Cash paid for income taxes	4,040	92	8
Series D-1 Preferred stock [Member]
Cash flows from financing activities:
Proceeds from issuance of Convertible Preferred stock, net			4,995
Series D-2 Preferred stock [Member]
Cash flows from financing activities:
Proceeds from issuance of Convertible Preferred stock, net		669
Receipts on account of Convertible Preferred stock			5,314
Series D-3 Preferred stock [Member]
Cash flows from financing activities:
Proceeds from issuance of Convertible Preferred stock, net		9,991
Series E Convertible Preferred stock [Member]
Cash flows from financing activities:
Proceeds from issuance of Convertible Preferred stock, net	$ 24,712

CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) $ in Thousands	12 Months Ended
	Jun. 30, 2013 USD ($)
CONSOLIDATED STATEMENTS OF CASH FLOWS
Proceeds from term loan, transaction fee	$ 100

GENERAL

12 Months Ended

Jun. 30, 2015

GENERAL [Abstract]

GENERAL

NOTE 1:- GENERAL

SolarEdge Technologies Inc. (the “Company”) and its subsidiaries design, develop, and sell an intelligent inverter solution that maximizes power generation at the individual photovoltaic (“PV”) module level while lowering the cost of energy produced by the solar PV system and providing comprehensive and advanced safety features. The Company's products consist mainly of (i) power optimizers which maximize energy throughput from each and every module through constant tracking of Maximum Power Point individually per module, (ii) inverters which invert direct current (DC) from the PV module to alternating current (AC) and (iii) a related cloud based monitoring platform, that collects and processes information from the power optimizers and inverters of a solar PV system to enable customers and system owners, as applicable, to monitor and manage the solar PV systems. The Company operates its business itself and through its wholly-owned subsidiaries: SolarEdge Technologies Ltd. in Israel; SolarEdge Technologies GmbH in Germany; SolarEdge Technologies (China) Co., Ltd in China; SolarEdge Technologies (Australia) PTY Ltd. in Australia; SolarEdge Technologies (Canada) Ltd. in Canada; SolarEdge Technologies (Holland) B.V. in the Netherlands; SolarEdge Technologies (UK) Ltd in United Kingdom; SolarEdge Technologies (Japan) Co., Ltd. in Japan and SolarEdge Technologies (France) in France (collectively, the “subsidiaries”). Except for SolarEdge Technologies Ltd in Israel, which carries out the research and development, management of manufacturing, global sales and support and management activities, the other subsidiaries are engaged solely in selling, marketing and support activities. The Company was incorporated in Delaware in August 2006 and began commercial sale of its products in January 2010.

Initial Public Offering:

On March 31, 2015, the Company closed its initial public offering (“IPO”) whereby 8,050,000 shares of common stock were sold by the Company to the public (inclusive of 1,050,000 shares of common stock pursuant to the full exercise of an overallotment option granted to the underwriters). The aggregate net proceeds received by the Company from the offering were approximately $131,208, net of underwriting discounts and commissions and offering expenses the majority of which have already been paid by the Company. Upon the closing of the IPO, all shares of the Company's outstanding convertible preferred stock automatically converted into 28,247,923 shares of common stock, and outstanding warrants to purchase convertible preferred stock automatically converted into warrants to purchase 187,671 shares of common stock (See Note 12).

As of June 30, 2015 and 2014, the Company had a major customer that accounted for approximately 24.6% and 19.1% of the Company's consolidated revenues, respectively.

The Company depends on two contract manufacturers and several limited or single source component suppliers. Reliance on these vendors makes the Company vulnerable to possible capacity constraints and reduced control over component availability, delivery schedules, manufacturing yields and costs. Two vendors collectively account for 79% and 60% of the Company's total trade payables as of June 30, 2015 and 2014, respectively.

SIGNIFICANT ACCOUNTING POLICIES

12 Months Ended

Jun. 30, 2015

SIGNIFICANT ACCOUNTING POLICIES [Abstract]

SIGNIFICANT ACCOUNTING POLICIES

NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES

The consolidated financial statements are prepared according to United States generally accepted accounting principles (“U.S. GAAP”).

a. Use of estimates:

The preparation of financial statements, in conformity with U.S. GAAP, requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The Company evaluates on an ongoing basis its assumptions, including those related to warranty obligation, warrants to purchase convertible preferred stock, contingencies, share-based compensation cost, as well as in estimates used in applying the revenue recognition policy. The Company's management believes that the estimates, judgment and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.

b. Financial statements in U.S. dollars:

The functional currency of the Company and its Israeli subsidiary is the U.S. dollar, as the U.S. dollar is the currency of the primary economic environment in which the Company has operated and expects to continue to operate in the foreseeable future. The Company's and its Israeli subsidiary's operations are currently primarily conducted in Israel and a significant portion of its expenses are currently paid in U.S. dollars. Financing activities including loans and cash investments, are mainly made in U.S. dollars.

Accordingly, monetary accounts maintained in currencies other than the U.S. dollar are translated into U.S. dollars in accordance with Financial Accounting Standards Board Accounting Standards Codification (“ASC”) 830 (“Foreign Currency Matters”). All transaction gains and losses of the re-measurement of monetary balance sheet items are reflected in the statements of operations as financial income or expenses, as appropriate.

The financial statements of the Company's German, Chinese, Australian, Canadian, Dutch, Japanese and French subsidiaries, whose functional currency is other than the U.S. dollar, have been translated into U.S dollars. Assets and liabilities have been translated using the exchange rates in effect on the balance sheet date. Statements of operations amounts have been translated using the average exchange rate for the relevant periods.

The resulting translation adjustments are reported as a component of stockholders' equity (deficiency) in accumulated other comprehensive income (loss).

Accumulated other comprehensive loss related to foreign currency translation adjustments, net amounted to $222, $61 and $26 as of June 30, 2015, 2014 and 2013, respectively.

c. Principles of consolidation:

The consolidated financial statements include the accounts of the Company and its subsidiaries. Intercompany transactions and balances including profits from intercompany sales not yet realized outside the Company have been eliminated upon consolidation.

The Company's fiscal years 2015, 2014 and 2013 ended on June 30, 2015, 2014 and 2013, respectively. Unless otherwise stated, references to particular years and quarters, refer to the Company's fiscal years ended in June and the associated quarters of those fiscal years.

d. Basic and Diluted Net Earnings (Loss) Per Share:

Basic net earnings (loss) per share is computed by dividing the net earnings (loss) by the weighted-average number of shares of common stock outstanding during the period.

Diluted net earnings (loss) per share is computed by giving effect to all potential shares of common stock, including stock options and convertible preferred stock, to the extent dilutive, all in accordance with FASB ASC No. 260, "Earnings Per Share."

The total weighted average number of shares related to the outstanding stock options, convertible preferred stock and warrants to purchase convertible preferred stock, excluded from the calculation of diluted net earnings (loss) per share due to their anti-dilutive effect was 20,565,747, 25,234,818 and 22,953,263, for the years ended June 30, 2015, 2014 and 2013, respectively.

Basic and diluted earnings (loss) per share is presented in conformity with the two-class method for participating securities for the periods prior to their conversion. Under this method the earnings per share for each class of shares are calculated assuming 100% of the Company's earnings are distributed as dividends to each class of shares based on their contractual rights. In addition, since all classes other than common stock do not participate in losses, for the twelve months period ended June 30, 2014 and 2013 these shares are not included in the computation of basic loss per share.

For the years ended June 30, 2014 and 2013 basic and diluted net loss per share was the same for each period presented as the inclusion of all potential shares of common stock outstanding would have been anti-dilutive.

The following table presents the computation of basic and diluted net earnings (loss) per share for the periods presented (in thousands, except per share data):

	Year ended June 30,
	2015	2014	2013
Net basic earnings (loss) per share of common stock:
Numerator:
Net income (loss)	21,121	(21,378)	(28,180)
Dividends accumulated for the period	(17,550)	-	-
Net income (loss) available to shareholders of common stock	3,571	(21,378)	(28,180)

Denominator:
Shares used in computing net earnings (loss) per share of common stock, basic	11,902,911	2,798,894	2,741,370


Net diluted earnings (loss) per share of common stock:
Numerator:
Net income (loss)	21,121	(21,378)	(28,180)
Dividends accumulated for the period	(16,971)	-	-
Net income (loss) available to shareholders of common stock	4,150	(21,378)	(28,180)

Denominator:
Shares used in computing net earnings (loss) per share of common stock, diluted	15,269,448	2,798,894	2,741,370

e. Cash and cash equivalents:

Cash equivalents are short-term, highly liquid investments that are readily convertible to cash, with original maturities of three months or less at the date acquired.

f. Restricted cash:

Restricted cash is primarily invested in short-term bank deposits, which are primarily used to guarantee a letter of credit which has been issued to one of the Company's major vendors and to the Company's landlords for its office leases.

g. Inventories:

Inventories are stated at the lower of cost or market value. Inventory reserves are provided to cover risks arising from slow-moving items or technological obsolescence.

The Company periodically evaluates the quantities on hand relative to historical, current and projected sales volume. Based on this evaluation, an impairment charge is recorded when required to write-down inventory to its market value. Cost of finished goods and raw materials is determined using the moving average cost method.

h. Property and equipment:

Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated by the straight-line method over the estimated useful lives of the assets, at the following rates:

		%

Computers and peripheral equipment		14 – 33 (mainly 33)
Office furniture and equipment		7 – 15 (mainly 7)
Machinery & equipment		7 – 33 (mainly 20)
Laboratory equipment		15 – 33 (mainly 15)
Vehicles		15
Leasehold improvements		over the shorter of the lease term or useful economic life

i. Impairment of long-lived assets:

The Company's long-lived assets are reviewed for impairment in accordance with ASC 360 (“Property, Plants and Equipment”), whenever events or changes in circumstances indicate that the carrying amount of an asset (or asset group) may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset (or asset group) to the future undiscounted cash flows expected to be generated by the assets (or asset group).

If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds their fair value. For the years ended June 30, 2015, 2014 and 2013, no impairment losses have been identified.

j. Severance pay:

Pursuant to Israel's Severance Pay Law, Israeli employees are entitled to severance pay equal to one month's salary for each year of employment, or a portion thereof. The employees of the Company's Israeli subsidiary have elected to be included under section 14 of the Severance Pay Law, 1963, under which these employees are entitled only to monthly deposits made in their name with insurance companies, at a rate of 8.33% of their monthly salary. These payments cause the Company to be released from any future obligation under the Israeli Severance Pay Law to make severance payments in respect of those employees; therefore, related assets and liabilities are not presented in the balance sheet.

For the years ended June 30, 2015, 2014 and 2013, the Company recorded $1,273, $1,109 and $974, severance expenses, respectively.

k. Revenue recognition:

The Company and its subsidiaries generate their revenues mainly from the sale of power optimizers, inverters and cloud-based monitoring services, to distributors, installers and PV module manufacturers.

Revenues from product sales and related services are recognized in accordance with ASC 605 (“Revenue Recognition”), when persuasive evidence of an arrangement exists, delivery has occurred, the selling price is fixed or determinable, collectability is reasonably assured and no significant obligations remain.

Persuasive evidence of an arrangement exists. The Company's customers mainly consist of distributors and installers (the “Customers”). The Company's sales arrangements with Customers are pursuant to written documentation, either a written contract or purchase order. The actual documentation used is dependent on the business practice with each Customer. Therefore, the Company determines that persuasive evidence of an arrangement exists with respect to a Customer when it has a written contract, or a binding purchase order from the Customer.

Delivery has occurred. Each item of written documentation relating to a sale arrangement that is agreed upon with the Customer specifically sets forth when risk of loss and title are being transferred (based on the agreed International Commercial terms, or “INCOTERMS”). Unless a different written arrangement with the Customer exists, the Company determines that risk of loss and title are transferred to the Customer when the applicable INCOTERMS are satisfied and thus delivery of its products has occurred.

The fee is fixed or determinable. The Company does not provide any price protection, stock rotation and/or right of return and thus the Company considers all the Customers as end-users and the fee is considered fixed and determinable upon execution of the written documentation with the Customers. Additionally, payments that are due within the normal course of the Company's credit terms, which are currently no more than three months from the delivery date, are deemed to be fixed and determinable. Fees and arrangements with payment terms extending beyond customary payment terms are considered not to be fixed or determinable, in which case revenues are deferred and recognized when payments become due, provided that all other revenue recognition criteria have been met.

Collectability is reasonably assured. The Company determines whether collectability is reasonably assured on a Customer-by-Customer basis pursuant to its credit review policy. The Company typically sells to Customers with whom it has a long-term business relationship and a history of successful collection. For a new Customer, or when an existing Customer substantially expands its commitments, the Company evaluates the Customer's financial position, the number of years the Customer has been in business, the history of collection with the Customer and the Customer's ability to pay and typically assigns a credit limit based on that review.

Provisions for rebates, sales incentives, and discounts to customers are accounted for as reductions in revenue in the same period the related sales are recorded.

The Company increases a credit limit only after it has established a successful collection history with the Customer. If the Company determines at any time that collectability is not reasonably assured under a particular arrangement based upon its credit review process, the Customer's payment history or information that comes to light about a Customer's financial position, it recognizes revenue under that arrangement as Customer payments are actually received.

Revenues related to cloud-based monitoring services are recognized ratably on a straight-line basis over the estimated service period of 25 years.

For multiple-element arrangements, the Company allocates revenue to all deliverables based on their relative selling prices. In such circumstances, the Company uses a hierarchy to determine the selling price to be used for allocating revenue to deliverables: (i) vendor-specific objective evidence of fair value (“VSOE”), (ii) third-party evidence of selling price (“TPE”), and (iii) best estimate of the selling price (“ESP”).

VSOE generally exists only when the Company sells the deliverable separately and is the price actually charged by the Company for that deliverable. ESPs reflect the Company's best estimates of what the selling prices of elements would be if they were sold regularly on a stand-alone basis. The Company has allocated revenue between its deliverables based on their relative selling prices. Because the Company has neither VSOE nor TPE for its deliverables, the allocation of revenue has been based on the Company's ESPs. Amounts allocated to the delivered elements are recognized at the time of sale provided the other conditions for revenue recognition have been met.

The Company's process for determining its ESP considers multiple factors that may vary depending upon the unique facts and circumstances related to each deliverable. Key factors considered by the Company in developing the ESPs for its products include prices charged by the Company for similar offerings, the Company's historical pricing practices and product-specific business objectives.

Deferred revenues consist of deferred web-based monitoring services, advance payments received from Customers for the Company's products and warranty extensions, and are classified as short-term and long-term deferred revenues based on the period in which revenues are expected to be recognized.

l. Cost of revenues:

Cost of revenues sold includes the following: product costs consisting of purchases from contract manufacturers and other suppliers, indirect manufacturing, support, warranty, provision for loss related to slow moving and dead inventory, personnel and logistics costs.

m. Shipping and handling costs:

Shipping and handling costs, which amounted to $26,931, $14,066 and $5,140 for the years ended June 30, 2015, 2014 and 2013, respectively, are included in cost of revenues in the consolidated statements of operations. Shipping and handling costs include all costs associated with the distribution of finished products from the Company's point of selling directly to its Customers.

n. Warranty obligations:

The Company's products include a minimum 12-year limited warranty for inverters and a 25-year limited warranty for power optimizers. In certain cases, the Company provides extended warranties for inverters that bring the warranty period up to 25 years. The Company maintains reserves to cover the expected costs that could result from these warranties. The potential liability is generally in the form of product replacement. Warranty reserves are based on the Company's best estimate of such costs and are included in cost of revenues. The reserve for the related warranty expenses is based on various factors including assumptions about the frequency of warranty claims on product failures, derived from results of accelerated lab testing, field monitoring, analysis of the history of product failures and the Company's reliability estimates.

The Company has established a reliability measurement system based on the units' estimated mean time between failure, or MTBF, a metric that equates to a steady-state failure rate per year for current generation products. The MTBF represents the predicted mean elapsed time to each product unit failure during system operation. The Company performs accelerated life cycle testing, which simulates the service life of the product in a short period of time.

The accelerated life cycle tests incorporate test methodologies derived from standard tests used by solar module vendors to evaluate the period over which solar modules wear out. Corresponding replacement costs are updated periodically to reflect changes in the Company's actual and estimated production costs for its products.

In addition, through the collection of actual failure statistics, the Company has identified several additional failure causes that are not included in the MTBF calculations. Such causes, which mostly consist of workmanship errors caused during the manufacturing process and replacement of non-faulty units by installers, are in addition to the replacement costs projected under the MTBF model. The Company identified each of those causes, its failure pattern and the relative ratio compared to the pattern of malfunctions identified under the MTBF and accrued additional provisions for the occurrence of such malfunctioning. The Company evaluates the continuation of these occurrences and the appearance of potential additional malfunctioning cases beyond the MTBF pattern and accrues additional expenses accordingly.

Warranty obligations are classified as short-term and long-term warranty obligations based on the period in which the warranty is expected to be claimed.

o. Royalty-bearing grants from the Binational Industrial Research and Development Foundation:

Royalty-bearing grants from the Binational Industrial Research and Development Foundation (“BIRD-F”) for funding of approved research and development projects are recognized, as a deduction from research and development expenses, at the time the Company is entitled to such grants (see Note 10c).

The Company recorded grants from BIRD-F in the amount of $248 for the year ended June 30, 2013, which was deducted from research and development expenses. No grants were recorded in the years ended June 30, 2015 and 2014.

p. Government grants:

Government grants received by the Company's Israeli subsidiary relating to categories of operating expenditures are credited to the consolidated statements of operations during the period in which the expenditure to which they relate is charged. Royalty bearing grants from the Israeli Office of the Chief Scientist (“OCS”) for funding certain approved research and development projects are recognized at the time when the Company's Israeli subsidiary is entitled to such grants, on the basis of the related costs incurred, and are included as a deduction from research and development expenses.

The Company recorded grants in the amount of $763 and $275 for the year ended June 30, 2015 and 2014, respectively, which was deducted from research and development expenses. No grants were recorded in the year ended June 30, 2013.

q. Research and development costs:

Research and development costs, net of grants received, are charged to the consolidated statement of operations as incurred.

r. Concentrations of credit risks:

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, restricted cash, trade receivables and other accounts receivable.

Cash and cash equivalents are mainly invested in major banks in the U.S., Israel and in Germany. Management believes that the financial institutions that hold the Company's investments are financially sound and, accordingly, minimal credit risk exists with respect to these investments.

The trade receivables of the Company are derived from sales to Customers located primarily in North America and Europe.

The Company generally does not require collateral, except for a partial advance payment; however, in certain circumstances, the Company may require letters of credit, other collateral or additional guarantees.

An allowance for doubtful accounts is determined with respect to specific debts that are doubtful of collection. As of June 30, 2015 the Company accrued $13 as allowance for doubtful accounts. As of June 30, 2014 and 2013 the Company did not accrue any allowance for doubtful accounts.

As of June 30, 2015 and 2014, the Company had a major Customer which accounted for approximately 30% and 31%, respectively, of the Company's consolidated trade receivables.

The Company and its subsidiaries have no off-balance sheet concentration of credit risk except for certain derivative instruments as mentioned below.

s. Fair value of financial instruments:

The following methods and assumptions were used by the Company in estimating the fair value of its financial instruments:

The carrying value of cash and cash equivalents, restricted cash, trade receivables, prepaid expenses and other accounts receivable, short term bank loan, trade payables, employees and payroll accruals and accrued expenses and other accounts payable approximate their fair values due to the short-term maturities of such instruments.

Assets measured at fair value on a recurring basis as of June 30, 2015 are comprised of foreign currency forward contracts.

Assets and liabilities measured at fair value on a recurring basis as of June 30, 2014 and 2013 are comprised of foreign currency forward contracts and warrants to purchase convertible preferred stock liability related to term loan (see Note 8).

The Company applies ASC 820 (“Fair Value Measurements and Disclosures”), with respect to fair value measurements of all financial assets and liabilities.

Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability.

A three-tier fair value hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value:

Level 1-

Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.

Level 2-

Include other inputs that are directly or indirectly observable in the marketplace.

Level 3-

Unobservable inputs which are supported by little or no market activity.

The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.

In accordance with ASC 820, the Company measures its foreign currency derivative contracts, at fair value using the market approach valuation technique. Foreign currency derivative contracts as detailed in Note 2w are classified within the Level 2 value hierarchy, as the valuation inputs are based on quoted prices and market observable data of similar instruments. Warrants to purchase convertible preferred stock as detailed in Note 8 are classified within the Level 3 value hierarchy.

t. Warrants to Purchase Convertible Preferred Stock:

The Company accounts for freestanding warrants to purchase shares of its convertible preferred stock as a liability on the balance sheets at fair value. The warrants to purchase convertible preferred stock are recorded as a liability because of a provision calling for minimum proceeds upon or after an “Exit Event”, as described in Note 8.

The fair value of warrants to purchase convertible preferred stock on the issuance date and on subsequent reporting dates was determined using a hybrid method utilizing the assumptions noted below. The fair value of the underlying preferred stock price was determined by the board of directors considering, among others, third party valuations. The valuation of the Company was performed using the hybrid method, a hybrid between the probability-weighted estimated return method (“PWERM”) and Option Pricing Method (“OPM”) estimating the probability-weighted value across multiple scenarios but using the OPM to estimate the allocation of value within one or more of those scenarios. The OPM was used to allocate the Company's equity value between the preferred stock, common stock and warrants in a scenario of other liquidation events.

The expected terms of the warrants were based on the remaining contractual expiration period. The expected share price volatility for the shares was determined by examining the historical volatilities of a group of the Company's industry peers as there was insufficient trading history of the Company's shares. The risk-free interest rate was calculated using the average of the published interest rates for U.S. Treasury zero-coupon issues with maturities that approximate the expected term.

The dividend yield assumption was zero as there is no history of dividend payments and since the Company does not expect to pay any didivends in the foreseeable future.

The following assumptions were used to estimate the value of the warrants to purchase convertible preferred stock:

	June 30,
	2014	2013

Expected volatility	45.0%	55.8%
Risk-free rate	0.09%	0.3%
Dividend yield	0%	0%
Expected term (in years)	1.21	1.50

The warrants to purchase convertible preferred stock were subject to re-measurement to fair value at each balance sheet date and any change in fair value was recognized as a component of financial expenses, net, on the statements of operations.

The change in the fair value of warrants to purchase convertible preferred stock is summarized below:

	Balance at beginning of period		Issuance of warrants to purchase preferred stock		Exercise of warrants to purchase common stock(*)		Change in fair value		Balance at end of period

June 30, 2015	$	765	$	-	$	(6,115)	$	5,350	$	-
June 30, 2014	$	818	$	-	$	-	$	(53)	$	765
June 30, 2013	$	-	$	778	$	-	$	40	$	818

(*)	Upon the closing of the IPO, all outstanding warrants to purchase convertible preferred stock automatically converted into warrants to purchase 187,671 shares of common stock (See Note 1b).

On June 18, 2015 the warrants were cashless exercised into 154,768 common shares. Immidiately before the cashless exercise the warrants were remessured to fair value based on their intrinsic value which amounted to $6,115 (see Note 8).

u. Accounting for stock-based compensation:

The Company accounts for stock-based compensation in accordance with ASC 718 (“Compensation-Stock Compensation”). ASC 718 requires companies to estimate the fair value of equity-based payment awards on the date of grant using an Option-Pricing Model (“OPM”). The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in the Company's consolidated statements of operations.

The Company recognizes compensation expenses for the value of its awards granted based on the straight-line method over the requisite service period of each of the awards, net of estimated forfeitures. ASC 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Estimated forfeitures are based on actual historical pre-vesting forfeitures.

The Company selected the Black-Scholes-Merton option pricing model as the most appropriate fair value method for its stock-option awards. The option-pricing model requires a number of assumptions, of which the most significant are the fair market value of the underlying common stock, expected stock price volatility and the expected option term. Expected volatility was calculated based upon certain peer companies that the Company considered to be comparable. The expected option term represents the period of time that options granted are expected to be outstanding. The expected option term is determined based on the simplified method in accordance with SAB No. 110, as adequate historical experience is not available to provide a reasonable estimate. The simplified method will continue to apply until enough historical experience is available to provide a reasonable estimate of the expected term. The risk-free interest rate is based on the yield from U.S. treasury bonds with an equivalent term. The Company has not declared or paid any dividends on its common stock and does not expect to pay any dividends in the foreseeable future.

The fair value of the shares of common stock underlying the stock options has historically been determined by the Company's management and approved by the board of directors. Because there has been no public market for the Company's common stock, the Company's management has determined fair value of the common stock by using, among other factors, third party valuations at the time of grant of the option by considering a number of objective and subjective factors, including data from other comparable companies, issuance of convertible preferred stock to unrelated third parties, operating and financial performance, the lack of liquidity of capital stock and general and industry specific economic outlook. The fair value of the underlying common stock was determined by the management until such time as the Company's common stock is listed on an established stock exchange or national market system. The Company's management determined the value of the shares of common stock based on valuations performed using the OPM for the years ended June 30, 2014 and 2013 and for the period from July 1, 2014 and up to March 31, 2015. From March 31, 2015 the common stock is publicly traded.

Since the distributions and participation rights to security holders until March 31, 2015 are different in a sale/liquidation scenario versus an IPO, the valuation of the Company's equity was performed using a discounted cash flow (DCF) model or a new investment round by external investors. The allocation of the Company's equity value between the convertible preferred stock, common stock and warrants was performed using a hybrid method between the PWERM and OPM estimating the probability-weighted value across multiple scenarios for liquidation events other than an IPO. Before the per share value was determined, a discount for lack of marketability and a voting right differential was applied, as applicable, to the common stock.

The fair value for options granted to employees and executive directors in the year ended June 30, 2015, 2014 and 2013 is estimated at the date of grant using a Black-Scholes-Merton option pricing model with the following assumptions:

	Year ended June 30,
	2015	2014	2013


Risk-free interest	1.39% - 2.06%	1.62% - 1.94%	0.74% - 1.00%
Dividend yields	0%	0%	0%
Volatility	46.5%-55.1%	46.3%-55.8%	55.8%-62.7%
Expected option term	5.50-6.27 years	6.02-6.27 years	6.08-6.27 years
Estimated forfeiture rate	12.5%-18.7%	14.0%	14.5%-20.9%

The following table set forth the parameters used in computation of the options compensation to non-employee consultants in the year ended June 30, 2015, 2014 and 2013, using a Black-Scholes-Merton option pricing model with the following assumptions:

	Year ended June 30,
	2015	2014	2013


Risk-free interest	1.49%-2.58%	1.95%-2.45%	0.98%-1.96%
Dividend yields	0%	0%	0%
Volatility	45.5%-56.2%	45.0%-55.8%	55.8%-62.7%
Contractual life	7.2-10.0 years	6.0-10.0 years	7.0-10.0 years

v. Income taxes:

The Company and its subsidiaries account for income taxes in accordance with ASC 740, “Income Taxes.” ASC 740 prescribes the use of the liability method, whereby deferred tax asset and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates that will be in effect when the differences are expected to reverse.

The Company and its subsidiaries provide a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value.

The Company accounts for uncertain tax positions in accordance with ASC 740. ASC 740-10 contains a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% (cumulative probability) likely to be realized upon ultimate settlement. The Company accrues interest and penalties related to unrecognized tax benefits under taxes on income.

w. Derivative financial instruments:

The Company accounts for derivatives and hedging based on ASC 815 (“Derivatives and Hedging”). ASC 815 requires the Company to recognize all derivatives on the balance sheet at fair value. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and, further, on the type of hedging relationship.

The Company entered into derivative instrument arrangements to hedge the Company's exposure to currencies other than the U.S. dollar. These derivative instruments are not designated as cash flow hedges, as defined by ASC 815, and therefore all gains and losses were recorded immediately in the statement of operations, as financial expenses, net.

As of June 30, 2015, 2014 and 2013, the Company recorded the fair value of derivative instruments in the amount of $859, $213 and $258, respectively in prepaid expenses and other accounts receivable.

x. Comprehensive income (loss):

The Company reports comprehensive income (loss) in accordance with ASC 220 (“Comprehensive Income”). ASC 220 establishes standards for the reporting and presentation of comprehensive income and its components in a full set of general purpose financial statements.

Total comprehensive income (loss) and the components of accumulated other comprehensive income (loss) are presented in the consolidated statements of stockholders' equity (deficiency). Accumulated other comprehensive income (loss) consists of foreign currency translation effects.

y. The impact of recently issued accounting standards still not effective for the Company as of June 30, 2015 is as follows:

In May 2014, the FASB issued an accounting standard update on revenue from contracts with customers, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers.

The new guidance will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. On July 9, 2015, the FASB agreed to delay the effective date by one year. In accordance with the agreed upon delay, the new standard is effective for the Company beginning January 1st, 2018. Early adoption is permitted, but not before the original effective date of the standard. The new standard is required to be applied retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying it recognized at the date of initial application. The Company is currently evaluating the effect that the new guidance will have on its consolidated financial statements and related disclosures. The Company has not yet selected a transition method nor has it determined the effect of the standard on its ongoing financial reporting.

z. Certain 2014 and 2013 figures have been reclassified to conform to the 2015 presentation. The reclassification had no effect on previously reported net loss or stockholders' equity (deficiency).

PREPAID EXPENSES AND OTHER ACCOUNTS RECEIVABLE

12 Months Ended

Jun. 30, 2015

PREPAID EXPENSES AND OTHER ACCOUNTS RECEIVABLE [Abstract]

PREPAID EXPENSES AND OTHER ACCOUNTS RECEIVABLE

NOTE 3:- PREPAID EXPENSES AND OTHER ACCOUNTS RECEIVABLE

	June 30,
	2015		2014

Contract manufacturers(*)	$	24,814	$	10,234
Government authorities		3,729		646
OCS		249		-
Prepaid expenses and other		2,994		2,038
Foreign currency derivative contracts		859		213
Deferred charges (see Note 8)		-		20

	$	32,645	$	13,151

(*)	Contract manufacturers receivables derive from the sale of components to manufacturing vendors who manufacture products for the Company. The Company purchases these components directly from suppliers. The Company does not reflect the sale of these components in revenues (see also Note 10e).

INVENTORIES

12 Months Ended

Jun. 30, 2015

INVENTORIES [Abstract]

INVENTORIES

NOTE 4:- INVENTORIES

	June 30,
	2015		2014


Raw materials	$	14,405	$	7,750
Finished goods		59,545		17,749

	$	73,950	$	25,499

The Company recorded inventory write-downs of $992, $1,131 and $428 for the years ended on June 30, 2015, 2014 and 2013, respectively.

PROPERTY AND EQUIPMENT

12 Months Ended

Jun. 30, 2015

PROPERTY AND EQUIPMENT [Abstract]

PROPERTY AND EQUIPMENT

NOTE 5:- PROPERTY AND EQUIPMENT

	June 30,
	2015		2014

Cost:

Computers and peripheral equipment	$	3,139	$	3,193
Office furniture and equipment		779		404
Laboratory and testing equipment		7,205		5,856
Machinery and equipment		6,936		2,491
Leasehold improvements		4,047		353
Vehicles		13		-

		22,119		12,297

Less - accumulated depreciation		7,402		6,946

Depreciated cost	$	14,717	$	5,351

Depreciation expenses for the years ended June 30, 2015, 2014 and 2013 were $2,253, $1,978 and $1,842, respectively.

ACCRUED EXPENSES AND OTHER ACCOUNTS PAYABLE

12 Months Ended

Jun. 30, 2015

ACCRUED EXPENSES AND OTHER ACCOUNTS PAYABLE [Abstract]

ACCRUED EXPENSES AND OTHER ACCOUNTS PAYABLE

NOTE 6:- ACCRUED EXPENSES AND OTHER ACCOUNTS PAYABLE

	June 30,
	2015		2014

Accrued expenses	$	5,271	$	2,807
Provision for contractual inventory purchase obligations *		1,304		1,317
OCS		-		146
Other		412		-

	$	6,987	$	4,270

* See also Note 10e.

WARRANTY OBLIGATIONS

12 Months Ended

Jun. 30, 2015

WARRANTY OBLIGATIONS [Abstract]

WARRANTY OBLIGATIONS

NOTE 7:- WARRANTY OBLIGATIONS

Changes in the Company's product warranty liability for the years ended on June 30, 2015 and 2014 were as follows:

	June 30,
	2015			2014

Balance, at beginning of year	$	18,181		$	10,378
Additions and adjustments to cost of revenues		19,407			11,861
Usage and current warranty expenses		(5,709	)		(4,058)

Balance, at end of year		31,879			18,181
Less current portion		(9,431	)		(5,496)

Long term portion	$	22,448		$	12,685

TERM LOAN AND WARRANTS TO PURCHASE CONVERTIBLE PREFERRED STOCK	12 Months Ended
	Jun. 30, 2015
TERM LOAN AND WARRANTS TO PURCHASE CONVERTIBLE PREFERRED STOCK [Abstract]
TERM LOAN AND WARRANTS TO PURCHASE CONVERTIBLE PREFERRED STOCK	NOTE 8:- TERM LOAN AND WARRANTS TO PURCHASE CONVERTIBLE PREFERRED STOCK On December 28, 2012 (the “Agreement Date”), the Company entered into a loan facility agreement (the “Loan Agreement”) with a lender (the “Lender”), pursuant to which the Lender agreed to loan the Company up to $10,000. On the Agreement Date, the Company received a total of $10,000, less a $100 loan transaction fee paid to the Lender (the “Loan”). The Loan is for a period of 42 months and bears annual interest of 11.90%, which is to be paid monthly. The principal of the loan is to be paid in 33 monthly payments, beginning in September 2013, except for the last loan payment which was paid in advance on the Agreement Date. Repayment of the Loan and payment of all other amounts owed to the Lender is paid in Euro. Borrowings pursuant to the Loan Agreement are secured by a first priority security interest in all existing and future assets of the Company, ranking junior to the Bank Lender's security interest as to the Company's trade receivables, inventory and cash and ranking pari passu with the Bank Lender's security interest as to all other collateral, including all equipment, intellectual property and all outstanding share capital of SolarEdge Technologies GmbH, SolarEdge Technologies Inc. and SolarEdge Technologies (China) Co., Ltd. (see Note 9). In connection with the Loan Agreement, the Company granted the Lender 563,014 warrants to purchase Series D-1 convertible preferred stock at an exercise price of $2.309 (the “Warrants”). The Warrants were exercisable in whole or in part prior to earliest of (i) the tenth anniversary of the Agreement Date or (ii) 12 months after a qualified initial public offering or (iii) immediately prior to the consumption of a merger or sale of all or substantially all of the Company's assets (“M&A Transaction”, and together with a qualified initial public offering, an “Exit Event”). If (i) the Lender exercised all Warrants in full upon or after an Exit Event, and (ii) the intrinsic value of the Warrants upon such exercise is lower than $750, the Company should pay to the Lender, in addition to any other amounts due to the Lender under the Loan Agreement, an amount equal to the difference between $750 and the Warrants' intrinsic value. On the Agreement Date, the Company recorded its freestanding Warrants to purchase its convertible preferred stock in the amount of $778 as a liability at their fair value upon issuance, by utilizing an option pricing method. The fair value of the Warrants was subject to remeasurement at each balance sheet date with any change in value being reflected as financial expenses, net. Upon exercise or expiration, the Warrants will be reclassified to stockholders' equity (deficiency), at which time the Warrant liability will no longer be subject to fair value accounting. The fair value of the Warrants liability on the Agreement Date in the amount of $778 represented a loan discount which was amortized to financial expenses over the period of the Loan by using the effective interest method. The residual amount of $9,122 (net of the $100 loan transaction fee) was allocated to the Loan. Issuance expenses in the amount of $75 were allocated to the warrants to purchase convertible preferred stock liability and to the Loan, according to the above recorded values ratio. Issuance expenses in the amount of $6 related to the Warrants liability were immediately expensed and recorded as financial expenses, net. Issuance expenses in the amount of $69 related to the Loan were recorded as deferred charge assets (classified to short-term and long-term assets). The deferred charge assets were amortized over the period of the Loan by using the effective interest method. Upon the closing of the IPO, all outstanding warrants to purchase convertible preferred stock automatically converted into warrants to purchase 187,671 shares of common stock (See Note 1b). As of June 30, 2014, the Warrants liability has been measured at fair value in the amount of $765. In January 2015, the Company fully settled the amount borrowed from Kreos under the Term Loan. On June 18, 2015 the Lender elected to exersice its cashless exercise rights under which the Company issued 154,768 shares of common stock. The fair value of the Warrants liability as of the exercise date in the amount of $6,115 was reclassified to stockholders' equity (deficiency).

REVOLVING CREDIT LINE	12 Months Ended
REVOLVING CREDIT LINE	Jun. 30, 2015
REVOLVING CREDIT LINE [Abstract]
REVOLVING CREDIT LINE	NOTE 9:- REVOLVING CREDIT LINE In June 2011, the Company entered into an agreement for a revolving line of credit from a Bank Lender (the "Bank Lender"), which, as amended to date, permits aggregate borrowings of up to $20 million in an amount not to exceed 80% of the eligible trade receivables plus 65% of inventories in transit to customers and bears interest, payable monthly, at the Bank Lender's prime rate plus a margin of 0.75% to 2.75%. The average interest rate on the Company's outstanding borrowings as of June 30, 2014 was 4.9%. On February 17, 2015, the Company amended and restated the agreement with the Bank Lender for a revolving line of credit, which permits aggregate borrowings of up to $40 million in an amount not to exceed 80% of the eligible accounts receivable and bears interest, payable monthly, at the Bank Lender's prime rate plus a margin of 0.5% to 2.0%. The amended and restated revolving line of credit will terminate, and outstanding borrowings will be payable, on December 31, 2016. In connection with the amended and restated revolving line of credit, the Company granted the Bank Lender security interests in substantially all of the Company's assets, including a first-priority security interest in the Company's trade receivables, cash and cash equivalents. Financial covenants contained in the agreement require the Company to maintain EBITDA and liquidity at specified levels. Specifically, the Company is required to maintain negative Adjusted EBITDA (defined in accordance with US GAAP as (a) net income, plus (b) the extent deducted in the calculation of net income, interest, taxes, depreciation and amortization, plus (c) to the extent deducted in the calculation of net income, non-cash stock-based compensation) of no greater than ($1,500) as of March 31, 2015, and positive Adjusted EBITDA of at least (i) $1,500 as of June 30, 2015, (ii) $3,500 as of September 30, 2015 and December 31, 2015, (iii) $1,500 as of March 31, 2016 and (iv) $3,500 for the fiscal year ended June 30, 2016 and for each calendar quarter thereafter. The Company is required to maintain liquidity (defined as unrestricted and unencumbered cash, plus availability under the amended and restated revolving line of credit) of $6,750. The amended and restated revolving line of credit also contains covenants that restrict the Company's ability to dispose of assets, engage in business combinations (or permit a subsidiary to engage in business combinations), grant liens, borrow money, or pay dividends. As of June 30, 2015 and 2014 the Company met all its Bank Lender covenants. As of June 30, 2015 the Company had no outstanding borrowings related to this revolving line of credit.

COMMITMENTS AND CONTINGENT LIABILITIES

12 Months Ended

Jun. 30, 2015

COMMITMENTS AND CONTINGENT LIABILITIES [Abstract]

COMMITMENTS AND CONTINGENT LIABILITIES

NOTE 10:- COMMITMENTS AND CONTINGENT LIABILITIES

a. Lease commitments:

The Company and its subsidiaries lease their operating facilities under non-cancelable operating lease agreements, which expire over the next ten years, with the last ending in December 2024.

The future minimum lease commitments of the Company and its subsidiaries under various non-cancelable operating lease agreements in respect of premises, that are in effect as of June 30, 2015, are as follows:

2016	$	2,256
2017		2,218
2018		2,156
2019		2,042
2020 and thereafter		8,706

	$	17,378

Rent expenses for the years ended June 30, 2015, 2014 and 2013 were approximately $1,714, $1,200 and $1,212 , respectively.

b. Guarantees:

As of June 30, 2015, contingent liabilities exist regarding guarantees in the amount of $813, $53 and $85 in respect of office rent lease agreements, customs transactions and credit card limits, respectively.

c. Royalty commitments:

On April 12, 2009, the Company received approval for a grant in a total amount of $703, from the BIRD-F in conjunction with a mutual development project with an American corporation.

Under the Company's research and development agreements with the BIRD-F, and pursuant to applicable law, the Company is required to pay royalties at the rate of 5% of gross sales of products developed with funds provided by the BIRD-F, up to an amount equal to 150% of the research and development grants (dollar-linked) received from the BIRD-F. The obligation to pay these royalties is contingent on actual sales of the products and, in the absence of such sales, no payment is required. Royalties payable with respect to grants received from the BIRD-F are linked to the Consumer Price Index in the U.S.

At the end of 2011, the American corporation that had partnered with the Company announced the discontinuation of its solar business, resulting in the termination of the mutual development agreements. As a result, the development has not advanced into a commercial product. The Company does not expect any revenues from such project or the utilization of the technology mutually developed.

As of June 30, 2015, the aggregate contingent liability to the BIRD-F amounted to approximately $1,135 which would be payable by the Company if the project were to generate revenues.

d. Governmental commitments:

The Company has received royalty-bearing grants sponsored by the Israeli government for the support of research and development activities. Through June 30, 2015, the Company had obtained grants from the OCS for certain of the Company's research and development projects. The Company is obligated to pay royalties to the OCS, amounting to 4% in the first three years, and 4.5% thereafter, of the sales of the products and other related revenues (based on the dollar equivalent amount of the grant) generated from such projects, up to 100% of the grants received. The royalty payment obligations also bear interest at the LIBOR rate. The obligation to pay these royalties is contingent on actual sales of the applicable products and in the absence of such sales, no payment is required. As of June 30, 2015 and 2014, there have been no sales or revenues on which royalties are payables.

As of June 30, 2015, the aggregate contingent liability to the OCS amounted to $771.

The Israeli Research and Development Law provides that know-how developed under an approved research and development program may not be transferred to third parties without the approval of the OCS. Such approval is not required for the sale or export of any products resulting from such research or development.

The OCS, under special circumstances, may approve the transfer of OCS-funded know-how outside Israel, in the following cases: (a) the grant recipient pays to the OCS a portion of the sale price paid in consideration for such OCS-funded know-how or in consideration for the sale of the grant recipient itself, as the case may be, which portion will not exceed six times the amount of the grants received plus interest (or three times the amount of the grant received plus interest, in the event that the recipient of the know-how has committed to retain the R&D activities of the grant recipient in Israel after the transfer); (b) the grant recipient receives know-how from a third party in exchange for its OCS-funded know-how; (c) such transfer of OCS-funded know-how arises in connection with certain types of cooperation in research and development activities; or (d) if such transfer of know-how arises in connection with a liquidation by reason of insolvency or receivership of the grant recipient.

e. Contractual purchase obligations:

The Company has contractual obligations to purchase goods and raw materials. These contractual purchase obligations relate to inventories held by contract manufacturers and purchase orders initiated by the contract manufacturers, which cannot be canceled without penalty. The Company utilizes third parties to manufacture its products. In addition, it acquires raw materials or other goods and services, including product components, by issuing to suppliers authorizations to purchase based on its projected demand and manufacturing needs. As of June 30, 2015, the Company had non-cancelable purchase obligations totaling approximately $92,071 out of which the Company already recorded a provision for loss in the amount of $1,304 (see also Note 6).

f. Legal claims:

	1.	From time to time, the Company may be involved in various claims and legal proceedings. The Company reviews the status of each matter and assesses its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and the amount can be reasonably estimated, the Company accrues a liability for the estimated loss. These accruals are reviewed at least quarterly and adjusted to reflect the impact of negotiations, settlements, rulings, advice of legal counsel and other information and events pertaining to a particular matter.

	2.	On February 6, 2012, SolarEdge Technologies Ltd. (“SolarEdge”) was served with a lawsuit filed by Appletech Ltd. (“Appletech”) in the Tel Aviv-Jaffa Court in an amount of NIS 2,208,000 ($642 as of June 30, 2014) alleging that SolarEdge owes payment under a manufacturing agreement and purchase orders. SolarEdge maintained that if any amounts should be deemed due, they would need to be offset with damages caused by Appletech and incurred by SolarEdge. SolarEdge filed a countersuit. The parties agreed to a summary judgment proceeding which was held in July 2014. On July 24, 2014, the judge ruled that SolarEdge is to pay NIS 1,725,000 ($502 as of June 30, 2014) to Appletech within 45 days of the judgment.

		A liability was recorded in the financial statements as of June 30, 2013 and 2014, and the amount of the judgment was paid in September 2014.

LEASE INCENTIVE OBLIGATION	12 Months Ended
LEASE INCENTIVE OBLIGATION	Jun. 30, 2015
LEASE INCENTIVE OBLIGATION [Abstract]
LEASE INCENTIVE OBLIGATION	NOTE 11:- LEASE INCENTIVE OBLIGATION The Company has a new operating lease agreement for building in Herzilia, Israel. In connection with this lease, the Company and its third party lessor (the "Lessor"), agreed that the Lessor would pay approximately $2,811 for certain leasehold improvements on behalf of the Company. As of June 30, 2015 the Company had received in cash $2,313 from the Lessor. These leasehold improvements are accounted for as a lease incentive obligation, which is recorded under long-term liabilities, net of the current portion recorded in accrued expenses and other accounts payable under current liabilities. The lease incentive obligation is being amortized over the life of the lease and as a reduction to rent expense.

CONVERTIBLE PREFERRED STOCK

12 Months Ended

Jun. 30, 2015

CONVERTIBLE PREFERRED STOCK [Abstract]

CONVERTIBLE PREFERRED STOCK

NOTE 12:- CONVERTIBLE PREFERRED STOCK

Composition of convertible preferred stock of the Company:

	Authorized			Issued and outstanding
		Number	of	shares
	June 30,
	2015	2014		2015	2014

Stock of $0.0001 par value:
Preferred stock	95,000,000	-		-	-
Series A Preferred stock	-	15,558,830		-	15,558,830
Series B Preferred stock	-	19,010,196		-	18,760,196
Series C Preferred stock	-	15,984,655		-	15,984,655
Series D Preferred stock	-	16,024,251		-	16,024,251
Series D-1 Preferred stock	-	5,100,000		-	2,165,441
Series D-2 Preferred stock (*)	-	2,598,528		-	2,598,528
Series D-3 Preferred stock	-	6,496,315		-	4,330,872
Series E Preferred stock(**)	-	-		-	-

	95,000,000	80,772,775		-	75,422,773

(*)	As of June 30, 2013, a total of $5,314 was received on account of preferred stock. The related 2,304,524 Series D-2 preferred stock were issued in July 2013.

(**)	In September 2014, the Company entered into a stock purchase agreement with new investors, pursuant to which the Company issued 9,321,019 shares of the Company's Series E Convertible Preferred stock for cash consideration of $25,000, which was received by the end of October 2014.

The Company issued Series A through E Preferred stock between the years 2006 and 2015. The Company classified the convertible preferred stock outside of stockholders' equity (deficiency) as required by ASC 480-10-S99-3A and ASR 268, since the shares possessed deemed liquidation features that could trigger a distribution of cash or assets not solely within the Company's control.

Prior to the consummation of the Company's IPO on March 31, 2015, the Company had the following convertible preferred stock outstanding, all of which was converted into common stock following with the IPO on March 31, 2015 (see Note 1b) which resulted in classification of convertible preferred stock temporary equity in the amount of $140,915 into stockholders' equity (deficiency):

	Shares Outstanding	Number of Shares of Common Stock issued upon conversion

Series A Preferred stock	15,558,830	5,186,276
Series B Preferred stock	18,760,196	6,253,398
Series C Preferred stock	15,984,655	5,328,217
Series D Preferred stock	16,024,251	5,341,416
Series D-1 Preferred stock	2,165,441	721,813
Series D-2 Preferred stock	2,598,528	866,175
Series D-3 Preferred stock	4,330,872	1,443,623
Series E Preferred stock	9,321,019	3,107,005
	84,743,792	28,247,923

STOCK CAPITAL

12 Months Ended

Jun. 30, 2015

STOCK CAPITAL [Abstract]

STOCK CAPITAL

NOTE 13:- STOCK CAPITAL

Composition of common stock capital of the Company:

	Authorized		Issued and outstanding

	Number of shares
	June 30,		June 30,
	2015	2014	2015	2014

Stock of $0.0001 par value:
Common stock	125,000,000	34,939,461	39,297,539	2,809,950

Common stock rights:

Common stock confers upon its holders the right to receive notice of, and to participate in, all general meetings of the Company, where each share of common stock shall have one vote for all purposes; to share equally, on a per share basis, in bonuses, profits or distributions out of fund legally available therefor; and to participate in the distribution of the surplus assets of the Company in the event of liquidation of the Company.

On March 23, 2015, the Company's board of directors and the requisite holders of the Company's capital stock consented to a 1-for-3 reverse stock split of the Company's common stock.

As a result of the reverse stock split, (i) every 3 shares of authorized, issued and outstanding common stock was decreased to one share of authorized, issued and outstanding common stock, (ii) the number of shares of common stock into which each outstanding warrant or option to purchase common stock is exercisable was proportionally decreased on a 1-for-3 basis, (iii) all share prices and exercise prices were proportionately increased. All of the share numbers, share prices, and exercise prices have been adjusted within these consolidated financial statements, on a retroactive basis, to reflect this 1-for-3 reverse stock split.

Stock option plans:

The Company's 2007 Global Incentive Plan (the “2007 Plan”) was adopted by the board of directors on August 30, 2007. The 2007 Plan terminated upon the Company's IPO on March 31, 2015 and no further awards may be granted thereunder. All outstanding awards will continue to be governed by their existing terms and 379,358 available options for future grant were transferred to the Company's 2015 Global Incentive Plan (the “2015 Plan”) and are reserved for future issuances under the 2015 plan.

The 2015 Plan became effective upon the consummation of the IPO. The 2015 Plan provides for the grant of options, RSUs and other share-based awards to directors, employees, officers and consultants of the Company and its Subsidiaries. As of June 30, 2015, a total of 1,822,484 shares of common stock were reserved for issuance pursuant to stock awards under the 2015 Plan (the “Share Reserve”).

The Share Reserve will automatically increase on January 1st of each year during the term of the 2015 Plan commencing on January 1st of the year following the year in which the 2015 Plan becomes effective in an amount equal to 5% of the total number of shares of capital stock outstanding on December 31st of the preceding calendar year; provided, however, that the Company's board of directors may determine that there will not be a January 1st increase in the Share Reserve in a given year or that the increase will be less than 5% of the shares of capital stock outstanding on the preceding December 31st. The aggregate maximum number of shares of common stock that may be issued on the exercise of incentive stock options is 10,000,000.

As of June 30, 2015, an aggregate of 1,755,044 options are still available for future grant under the 2015 Plan.

In addition, the Company adopted an Employee Stock Purchase Plan (the “ESPP”) effective upon the consummation of the IPO. As of June 30, 2015, a total of 487,643 shares reserved for issuance under this plan. The number of shares of common stock reserved for issuance under the ESPP will increase automatically on January 1st of each year, for ten years, by the lesser of 1% of the total number of shares of the Company's common stock outstanding on December 31st of the preceding calendar year or 487,643 shares.

However, the Company's board of directors may reduce the amount of the increase in any particular year at their discretion, including a reduction to zero.

A summary of the activity in the share options granted to employees and members of the board of directors for the year ended June 30, 2015 and related information follows:

						Weighted
						average
				Weighted		remaining
	Number			average		contractual		Aggregate
	of			exercise		term		intrinsic
	options			price		in years		Value

Outstanding as of July 1, 2014		4,007,116		$	2.13		6.82	$	6,384
Granted		2,183,563		$	4.89
Exercised		(31,981	)	$	2.36
Forfeited or expired		(56,476	)	$	3.42
Outstanding as of June 30, 2015		6,102,222		$	3.10		7.08	$	202,889

Vested and expected to vest as of June 30, 2015		5,809,767		$	3.04		7.00	$	193,518

Exercisable as of June 30, 2015		3,551,239		$	2.17		5.71	$	121,373

A summary of the activity in the share options granted to employees and members of the board of directors for the year ended June 30, 2014 and related information follows:

						Weighted
						average
				Weighted		remaining
	Number			average		contractual		Aggregate
	of			exercise		term		intrinsic
	options			price		in years		Value

Outstanding as of July 1, 2013		3,625,366		$	1.92		7.39	$	5,757
Granted		575,457		$	3.41
Exercised		(27,459	)	$	1.86
Forfeited or expired		(166,248	)	$	2.16
Outstanding as of June 30, 2014		4,007,116		$	2.13		6.82	$	6,384

Vested and expected to vest as of June 30, 2014		3,746,620		$	2.07		6.69	$	6,175

Exercisable as of June 30, 2014		2,719,543		$	1.81		6.08	$	5,206

The aggregate intrinsic value in the tables above represents the total intrinsic value (the difference between the fair value of the Company's common stock as of the last day of each period and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on the last day of each period.

The total intrinsic value of options exercised during the year ended June 30, 2015 and 2014 was $484 and $58, respectively.

The weighted average grant date fair values of options granted to employees and executive directors during the years ended June 30, 2015, 2014 and 2013 were $7.57, $0.66 and $0.52, respectively.

The options outstanding as of June 30, 2015, have been separated into exercise price ranges as follows:

	Options		Weighted		Options		Weighted
	outstanding		average		exercisable		average
Range of	as of		remaining		as of		remaining
exercise	June 30,		contractual		June 30,		contractual
price	2015		Life in years		2015		Life in years

$0.87		557,605		3.94		490,165		3.14
$1.50 - $1.68		771,321		4.04		771,321		4.04
$2.01 - $2.46		2,075,550		6.30		1,794,228		6.24
$3.03 - $3.96		668,270		8.54		247,767		8.46
$5.01 - $5.04		1,996,148		9.42		247,758		9.40
$9.36		33,328		9.59		-		-

		6,102,222		7.08		3,551,239		5.71

The options outstanding as of June 30, 2014, have been separated into exercise price ranges as follows:

	Options		Weighted		Options		Weighted
	outstanding		average		exercisable		average
Range of	as of		remaining		as of		remaining
exercise	June 30,		contractual		June 30,		contractual
price	2014		Life in years		2014		Life in years

$0.87		490,165		4.14		490,165		4.14
$1.50 - $1.68		779,653		5.05		774,185		5.05
$2.01 - $2.46		2,114,517		7.31		1,388,628		7.19
$3.03 - $3.51		622,781		9.46		66,565		9.19

		4,007,116		6.82		2,719,543		6.08

Options issued to non-employee consultants:

The Company has granted options to purchase common shares to non-employee consultants as of June 30, 2015 as follows:

	Options
	outstanding				Exercisable
	as of				as of
Issuance	June 30,		Exercise		June 30,		Exercisable
Date	2015		price		2015		Through

July 31, 2008		33,333	$	0.87		33,333	July 31, 2018
January 26, 2011		5,000	$	2.01		5,000	January 26, 2021
January 26, 2012		33,333	$	2.46		33,333	January 26, 2022
October 24, 2012		6,666	$	2.46		4,583	October 24, 2022
January 23, 2013		3,333	$	3.03		2,153	January 23, 2023
January 27, 2014		4,998	$	3.51		1,652	January 27, 2024
May 1, 2014		6,000	$	3.51		2,042	May 1, 2024
September 17, 2014		19,163	$	3.96		3,662	September 17, 2024
October 29, 2014		6,668	$	5.01		890	October 29, 2024

		118,494				86,648

The Company has granted options to purchase common shares to non-employee consultants as of June 30, 2014 as follows:

	Options
	outstanding				Exercisable
	as of				as of
Issuance	June 30,		Exercise		June 30,		Exercisable
Date	2014		price		2014		Through

July 31, 2008		33,333	$	0.87		33,333	July 31, 2018
January 26, 2011		5,000	$	2.01		5,000	January 26, 2021
January 26, 2012		33,333	$	2.46		27,778	January 26, 2022
October 24, 2012		6,666	$	2.46		2,916	October 24, 2022
January 23, 2013		8,333	$	3.03		3,298	January 23, 2023
January 27, 2014		4,998	$	3.51		139	January 27, 2024
May 1, 2014		6,000	$	3.51		-	May 1, 2024

		97,663				72,464

The Company accounts for its options granted to non-employee consultants under the fair value method of ASC 505-50 (“Equity-Based Payments to Non-Employees”).

In connection with the grant of stock options to non-employee consultants, the Company recorded stock compensation expenses in the years ended June 30, 2015, 2014 and 2013 in the amounts of $563, $55 and $45, respectively.

Stock-based compensation expense for employees and non-employee consultants:

The Company recognized stock-based compensation expenses related to stock options granted to employees and non-employee consultants in the consolidated statement of operations for the years ended June 30, 2015, 2014 and 2013, as follows:

	Year ended June 30,
	2015		2014		2013

Cost of revenues	$	442	$	108	$	88
Research and development, net		635		397		381
Selling and marketing		809		297		317
General and administrative		1,070		280		292

Total stock-based compensation expense	$	2,956	$	1,082	$	1,078

As of June 30, 2015, there was a total unrecognized compensation expense of $10,577 related to non-vested equity-based compensation arrangements granted under the Company's Plan. These expenses are expected to be recognized during the period from July 1, 2015 through October 31, 2019.

INCOME TAXES

12 Months Ended

Jun. 30, 2015

INCOME TAXES [Abstract]

INCOME TAXES

NOTE 14:- INCOME TAXES

a. Tax rates in U.S. and Germany:

The Company is subject to U.S. federal tax at the rate of 35%, and the Company's German subsidiary is subject to German tax at the rate of 33%.

b. Corporate tax in Israel:

Taxable income of Israeli companies is subject to corporate tax at the rate of 25% in the year ended June 30, 2013, and 26.5% in the year ended June 30, 2014 onwards.

c. Carryforward tax losses:

As of June 30, 2015, the Israeli subsidiary has approximately $84,700 of Israeli net carryforward tax losses, which has no expiration date.

As of June 30, 2015, the Company has no federal carryforward tax losses.

As of June 30, 2015 , the Company has net operating loss carryforwards for California income tax purposes of approximately $9,794.

The state net operating loss carryforwards, if not utilized, will expire beginning in 2031. Utilization of the net operating loss carryforwards may be subject to a substantial annual limitation due to the ownership change limitations provided by the Internal Revenue Code of 1986, as amended (the “Code”), and similar state provisions. The annual limitation may result in the expiration of net operating losses before utilization.

d. Deferred income taxes:

Deferred income taxes reflect the net tax effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.

Significant components of the Company's deferred tax liabilities and assets are as follows:

	June 30,
	2015			2014

Assets in respect of:

Carryforward tax losses (1)	$	23,033		$	32,203
Research and Development carryforward expenses- temporary differences		5,173			4,310
Other reserves		1,346			786

		29,552			37,299

Valuation allowance (2)		(29,552	)		(37,299	)

Net deferred tax assets	$	-		$	-

(1)	See Note 14c.

(2)

The Company has provided full valuation allowances as of June 30, 2015 and 2014 on deferred tax assets resulting from carryforward tax losses, research and development carryforward expenses and other reserves due to its history of operating losses and current uncertainty concerning the ability to realize these deferred tax assets in the future.

Undistributed earnings of certain subsidiaries as of June 30, 2015 were immaterial. The Company intends to reinvest these earnings indefinitely in the foreign subsidiaries. As a result, the Company has not provided for any deferred income taxes.

e. Income (loss) before taxes is comprised as follows:

	Year ended June 30,
	2015		2014

Domestic	$	2,830	$	661
Foreign		20,246		(21,819	)

	$	23,076	$	(21,158	)

f. Taxes on income are comprised as follows:

	Year ended June 30,
	2015		2014		2013

Federal	$	1,270	$	11	$	-
State		180		89		-
Foreign		300		120		108
Taxes on income related to prior years		205		-		-

	$	1,955	$	220	$	108

g. Reconciliation of theoretical tax expense to actual tax expense:

The differences between the statutory tax rate of the Company and the effective tax rate are primarily accounted for by the non-recognition of tax benefits from accumulated net carryforward tax losses among the Company and various subsidiaries due to uncertainty of the realization of such tax benefits.

A reconciliation between the theoretical tax expense, assuming all income is taxed at the statutory tax rate applicable to income of the Company, and the actual tax expense (benefit) as reported in the consolidated statements of operations is as follows:

	Year ended June 30,
	2015			2014			2013


Income (loss) before taxes, as reported in the consolidated statements of operations	$	23,076		$	(21,158	)	$	(28,072	)

Statutory tax rate		35			35			35
Theoretical tax benefits on the above amount at the US statutory tax rate		8,077			(7,405	)		(9,825	)
Income tax at rate other than the U.S. statutory tax rate		(1,763	)		2,007			2,167
Impact of Israel corporate tax rate change from 25% to 26.5%		-			(2,103	)		-
Taxes on income related to prior years		205			-			-
Non-deductible expenses including equity based compensation expenses		3,003			467			300
Operating losses and other temporary differences for which valuation allowance was provided		(7,747	)		7,165			7,466
State tax		180			89			-

Actual tax expense	$	1,955		$	220		$	108

h. Tax assessments:

As of June 30, 2015, the Company and certain of its subsidiaries filed U.S. federal and various state and foreign income tax returns. The statute of limitations relating to the consolidated U.S. federal income tax return is closed for all tax years up to and including 2011.

The statute of limitations related to tax returns of the Company's Israeli subsidiary is closed for all tax years up to and including 2010.

With respect to the Company's German, Chinese, Australian, Canadian, Dutch, Japaneese, UK and French subsidiaries, the statute of limitations related to its tax returns is open for all tax years since incorporation.

The Company believes that it has adequately provided for any reasonably foreseeable outcome related to tax audits and settlements. The final tax outcome of any Company tax audits could be different from that which is reflected in the Company's income tax provisions and accruals. Such differences could have a material effect on the Company's income tax provision and net income (loss) in the period in which such determination is made.

i. Tax benefits for Israeli companies under the Law for the Encouragement of Capital Investments, 1959 (the “Investment Law”):

The Israeli subsidiary elected tax year 2012 as a "Year of Election" for “Beneficiary Enterprise” status under the Investment Law, which provides certain benefits, including tax exemptions and reduced tax rates. Income not eligible for Beneficiary Enterprise benefits is taxed at a regular corporate tax rate. Upon meeting the requirements under the Investment Law, income derived from Beneficiary Enterprise from productive activity will be exempt from tax for two years from the year in which the Israeli subsidiary first has taxable income, provided that 12 years have not passed from the beginning of the year of election.

If dividends are distributed out of tax exempt profits, the Israeli subsidiary will then become liable for tax at the rate applicable to its profits from the Beneficiary Enterprise in the year in which the income was earned, as if it had not chosen the alternative track of benefits.

The dividend recipient is subject to withholding tax at the rate of 15% applicable to dividends from Beneficiary enterprises, if the dividend is distributed during the tax benefits period or within twelve years thereafter. This limitation does not apply to a foreign investors' company. The Israeli subsidiary currently has no plans to distribute dividends and intends to retain future earnings to finance the development of its business.

Through June 30, 2015, the Israeli subsidiary had not generated income under the provision of the Investment Law.

In December 2010, the Israeli Parliament passed the Law for Economic Policy for 2011 and 2012 (Amended Legislation), which, among other things, included an amendment to the Investment Law, effective as of January 1, 2011 (the “Amendment”). In accordance with the 2011 Amendment, the benefit tracks under the Investment Law were modified and a uniform tax rate would apply to companies eligible for the “Preferred Enterprise” status (rather than the previous terminology of “Beneficiary Enterprise”). Companies may elect to irrevocably implement the 2011 Amendment (while waiving benefits provided under the Investment Law as then in effect).

On July 30, 2013, the Israeli Parliament passed a law, which, among other things, was designated to amend the uniform tax rates that were set in the 2011 Amendment, and to increase the tax levy for years 2013 and 2014 (the “New Law”). The New Law increases the Israeli corporate tax rate from 25% to 26.5%, cancels the reduction of corporate tax rate for “Preferred Enterprises”, which was set at 16% for 2014 and succeeding years under the New Law and increases the tax rate on dividends from sources under the Prefeed Enterprise status to 20% commencing on January 1, 2014.

The Israeli subsidiary currently does not intend to implement the Amendment.

j. Tax benefits under Israel's Law for Encouragement of Industry (Taxation), 1969:

The Israeli entity is an "industrial company" under the Law for the Encouragement of Industry (Taxation), 1969, and as such is entitled to certain tax benefits, mainly the amortization of costs relating to know-how and patents, over eight years and accelerated depreciation.

The following corporate tax benefits, among others, are available to Industrial Companies:

amortization of the cost of purchased a patent, rights to use a patent, and know-how, which are used for the development or advancement of the company, over an eight-year period, commencing on the year in which such rights were first exercised;
under limited conditions, an election to file consolidated tax returns with related Israeli Industrial Companies; and
expenses related to a public offering are deductible in equal amounts over three years.

Eligibility for benefits under the Industry Encouragement Law is not contingent upon approval of any governmental authority.

There can be no assurance that the Company will continue to qualify as an Industrial Company or that the benefits described above will be available in the future.

FINANCIAL EXPENSES (INCOME), NET

12 Months Ended

Jun. 30, 2015

FINANCIAL EXPENSES (INCOME), NET [Abstract]

FINANCIAL EXPENSES (INCOME), NET

NOTE 15:-

FINANCIAL EXPENSES (INCOME), NET

	Year ended June 30,
	2015			2014			2013

Remeasurement of warrants to purchase convertible preferred stock	$	5,350		$	(53	)	$	40
Interest on term loan		579			1,475			794
Other financial expenses related to term loan		373			31			21
Expenses (income) related to hedging transaction		(1,721	)		189			(207	)
Interest on short- term loan		316			537			276
Exchange rate loss (income), net, bank charges and other finance expenses		180			608			(312	)

	$	5,077		$	2,787		$	612

GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA

12 Months Ended

Jun. 30, 2015

GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA [Abstract]

GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA

NOTE 16:- GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA

Summary information about geographic areas:

ASC 280 (“Segment Reporting”) establishes standards for reporting information about operating segments. Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company manages its business on the basis of one reportable segment, and derives revenues from selling its products (see Note 1a for a brief description of the Company's business).

The following is a summary of revenues within geographic areas:

	Year ended June 30,
	2015		2014		2013

Revenues based on Customers' location:
United States	$	238,340	$	64,607	$	15,334
Germany		13,290		15,133		12,692
Europe (*)		52,163		38,655		40,367
Rest of the World		21,285		14,822		10,642
Total revenues	$	325,078	$	133,217	$	79,035

(*)	Except for Germany

Major Customers data as a percentage of total revenues:

Year ended
June 30,

2015

2014

2013

Customer A

24.6%

19.1%

*)	Less than 10%.

The following is a summary of revenues by product family :

	Year ended June 30,
	2015		2014		2013

Inverters	$	156,984	$	62,085	$	35,422
Optimizers		158,513		65,018		38,337
Others		9,581		6,114		5,276
Total revenues	$	325,078	$	133,217	$	79,035

Long-lived assets by geographic region:

	Year ended June 30,
	2015		2014

Israel	$	14,136	$	5,025
Europe		230		211
U.S.		342		112
Other		9		3

Total long-lived assets*	$	14,717	$	5,351

*	Long-lived assets are comprised of property and equipment, net (long term lease deposits and severance pay fund are not included).

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 33
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 35
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8906-108599

+ Details

SUBSEQUENT EVENTS	12 Months Ended
SUBSEQUENT EVENTS	Jun. 30, 2015
SUBSEQUENT EVENTS [Abstract]
SUBSEQUENT EVENTS	NOTE 17:- SUBSEQUENT EVENTS On January 9, 2015, a patent infringement lawsuit was filed by Beacon Power LLC, a Delaware limited liability company (“Beacon”), against the Company and a third party in the United States District Court for the Western District of Texas, San Antonio Division which alleges infringement by the Company of two U.S. patents. On March 9, 2015, the Company and Beacon entered into a patent purchase agreement under which the Company agreed to purchase all rights in the aforementioned patents and Beacon agreed to dismiss all outstanding claims against the Company. In July 2015 the Company completed the purchase in return for total consideration of $800.

SIGNIFICANT ACCOUNTING POLICIES (Policies)

12 Months Ended

Jun. 30, 2015

SIGNIFICANT ACCOUNTING POLICIES [Abstract]

Use of estimates

a. Use of estimates:

Financial statements in U.S. dollars

b. Financial statements in U.S. dollars:

The resulting translation adjustments are reported as a component of stockholders' equity (deficiency) in accumulated other comprehensive income (loss).

Accumulated other comprehensive loss related to foreign currency translation adjustments, net amounted to $222, $61 and $26 as of June 30, 2015, 2014 and 2013, respectively.

Principles of consolidation

c. Principles of consolidation:

Basic and Diluted Net Earnings (Loss) Per Share

d. Basic and Diluted Net Earnings (Loss) Per Share:

Basic net earnings (loss) per share is computed by dividing the net earnings (loss) by the weighted-average number of shares of common stock outstanding during the period.

The following table presents the computation of basic and diluted net earnings (loss) per share for the periods presented (in thousands, except per share data):

	Year ended June 30,
	2015	2014	2013
Net basic earnings (loss) per share of common stock:
Numerator:
Net income (loss)	21,121	(21,378)	(28,180)
Dividends accumulated for the period	(17,550)	-	-
Net income (loss) available to shareholders of common stock	3,571	(21,378)	(28,180)

Denominator:
Shares used in computing net earnings (loss) per share of common stock, basic	11,902,911	2,798,894	2,741,370


Net diluted earnings (loss) per share of common stock:
Numerator:
Net income (loss)	21,121	(21,378)	(28,180)
Dividends accumulated for the period	(16,971)	-	-
Net income (loss) available to shareholders of common stock	4,150	(21,378)	(28,180)

Denominator:
Shares used in computing net earnings (loss) per share of common stock, diluted	15,269,448	2,798,894	2,741,370

Cash and cash equivalents

e. Cash and cash equivalents:

Cash equivalents are short-term, highly liquid investments that are readily convertible to cash, with original maturities of three months or less at the date acquired.

Restricted cash

f. Restricted cash:

Inventories

g. Inventories:

Inventories are stated at the lower of cost or market value. Inventory reserves are provided to cover risks arising from slow-moving items or technological obsolescence.

Property and equipment

h. Property and equipment:

		%

Computers and peripheral equipment		14 – 33 (mainly 33)
Office furniture and equipment		7 – 15 (mainly 7)
Machinery & equipment		7 – 33 (mainly 20)
Laboratory equipment		15 – 33 (mainly 15)
Vehicles		15
Leasehold improvements		over the shorter of the lease term or useful economic life

Impairment of long-lived assets

i. Impairment of long-lived assets:

Severance pay

j. Severance pay:

For the years ended June 30, 2015, 2014 and 2013, the Company recorded $1,273, $1,109 and $974, severance expenses, respectively.

Revenue recognition

k. Revenue recognition:

Provisions for rebates, sales incentives, and discounts to customers are accounted for as reductions in revenue in the same period the related sales are recorded.

Revenues related to cloud-based monitoring services are recognized ratably on a straight-line basis over the estimated service period of 25 years.

Cost of revenues

l. Cost of revenues:

Shipping and handling costs

m. Shipping and handling costs:

Warranty obligations

n. Warranty obligations:

Warranty obligations are classified as short-term and long-term warranty obligations based on the period in which the warranty is expected to be claimed.

Royalty-bearing grants from the Binational Industrial Research and Development Foundation

o. Royalty-bearing grants from the Binational Industrial Research and Development Foundation:

Government grants

p. Government grants:

Research and development costs

q. Research and development costs:

Research and development costs, net of grants received, are charged to the consolidated statement of operations as incurred.

Concentrations of credit risks

r. Concentrations of credit risks:

The trade receivables of the Company are derived from sales to Customers located primarily in North America and Europe.

As of June 30, 2015 and 2014, the Company had a major Customer which accounted for approximately 30% and 31%, respectively, of the Company's consolidated trade receivables.

The Company and its subsidiaries have no off-balance sheet concentration of credit risk except for certain derivative instruments as mentioned below.

Fair value of financial instruments

s. Fair value of financial instruments:

The following methods and assumptions were used by the Company in estimating the fair value of its financial instruments:

Assets measured at fair value on a recurring basis as of June 30, 2015 are comprised of foreign currency forward contracts.

The Company applies ASC 820 (“Fair Value Measurements and Disclosures”), with respect to fair value measurements of all financial assets and liabilities.

A three-tier fair value hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value:

Level 1-

Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.

Level 2-

Include other inputs that are directly or indirectly observable in the marketplace.

Level 3-

Unobservable inputs which are supported by little or no market activity.

The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.

Warrants to Purchase Convertible Preferred Stock

t. Warrants to Purchase Convertible Preferred Stock:

The dividend yield assumption was zero as there is no history of dividend payments and since the Company does not expect to pay any didivends in the foreseeable future.

The following assumptions were used to estimate the value of the warrants to purchase convertible preferred stock:

	June 30,
	2014	2013

Expected volatility	45.0%	55.8%
Risk-free rate	0.09%	0.3%
Dividend yield	0%	0%
Expected term (in years)	1.21	1.50

The change in the fair value of warrants to purchase convertible preferred stock is summarized below:

	Balance at beginning of period		Issuance of warrants to purchase preferred stock		Exercise of warrants to purchase common stock(*)		Change in fair value		Balance at end of period

June 30, 2015	$	765	$	-	$	(6,115)	$	5,350	$	-
June 30, 2014	$	818	$	-	$	-	$	(53)	$	765
June 30, 2013	$	-	$	778	$	-	$	40	$	818

(*)	Upon the closing of the IPO, all outstanding warrants to purchase convertible preferred stock automatically converted into warrants to purchase 187,671 shares of common stock (See Note 1b).

Accounting for stock-based compensation

u. Accounting for stock-based compensation:

	Year ended June 30,
	2015	2014	2013


Risk-free interest	1.39% - 2.06%	1.62% - 1.94%	0.74% - 1.00%
Dividend yields	0%	0%	0%
Volatility	46.5%-55.1%	46.3%-55.8%	55.8%-62.7%
Expected option term	5.50-6.27 years	6.02-6.27 years	6.08-6.27 years
Estimated forfeiture rate	12.5%-18.7%	14.0%	14.5%-20.9%

	Year ended June 30,
	2015	2014	2013


Risk-free interest	1.49%-2.58%	1.95%-2.45%	0.98%-1.96%
Dividend yields	0%	0%	0%
Volatility	45.5%-56.2%	45.0%-55.8%	55.8%-62.7%
Contractual life	7.2-10.0 years	6.0-10.0 years	7.0-10.0 years

Income taxes

v. Income taxes:

The Company and its subsidiaries provide a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value.

Derivative financial instruments

w. Derivative financial instruments:

As of June 30, 2015, 2014 and 2013, the Company recorded the fair value of derivative instruments in the amount of $859, $213 and $258, respectively in prepaid expenses and other accounts receivable.

Comprehensive income (loss)

x. Comprehensive income (loss):

Impact of recently issued accounting standards

y. The impact of recently issued accounting standards still not effective for the Company as of June 30, 2015 is as follows:

Reclassification

z. Certain 2014 and 2013 figures have been reclassified to conform to the 2015 presentation. The reclassification had no effect on previously reported net loss or stockholders' equity (deficiency).

SIGNIFICANT ACCOUNTING POLICIES (Tables)

12 Months Ended

Jun. 30, 2015

SIGNIFICANT ACCOUNTING POLICIES [Abstract]

Schedule of computation of basic and diluted net earnings (loss) per share

	Year ended June 30,
	2015	2014	2013
Net basic earnings (loss) per share of common stock:
Numerator:
Net income (loss)	21,121	(21,378)	(28,180)
Dividends accumulated for the period	(17,550)	-	-
Net income (loss) available to shareholders of common stock	3,571	(21,378)	(28,180)

Denominator:
Shares used in computing net earnings (loss) per share of common stock, basic	11,902,911	2,798,894	2,741,370


Net diluted earnings (loss) per share of common stock:
Numerator:
Net income (loss)	21,121	(21,378)	(28,180)
Dividends accumulated for the period	(16,971)	-	-
Net income (loss) available to shareholders of common stock	4,150	(21,378)	(28,180)

Denominator:
Shares used in computing net earnings (loss) per share of common stock, diluted	15,269,448	2,798,894	2,741,370

Schedule of estimated useful lives of property and equipment

		%

Computers and peripheral equipment		14 – 33 (mainly 33)
Office furniture and equipment		7 – 15 (mainly 7)
Machinery & equipment		7 – 33 (mainly 20)
Laboratory equipment		15 – 33 (mainly 15)
Vehicles		15
Leasehold improvements		over the shorter of the lease term or useful economic life

Summary of change in fair value of warrants to purchase convertible preferred stock

	Balance at beginning of period		Issuance of warrants to purchase preferred stock		Exercise of warrants to purchase common stock(*)		Change in fair value		Balance at end of period

June 30, 2015	$	765	$	-	$	(6,115)	$	5,350	$	-
June 30, 2014	$	818	$	-	$	-	$	(53)	$	765
June 30, 2013	$	-	$	778	$	-	$	40	$	818

Warrants to purchase convertible preferred stock [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of assumptions used to estimate fair value of stock options and warrants

	June 30,
	2014	2013

Expected volatility	45.0%	55.8%
Risk-free rate	0.09%	0.3%
Dividend yield	0%	0%
Expected term (in years)	1.21	1.50

Stock Option [Member] | Employees and executive directors [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of assumptions used to estimate fair value of stock options and warrants

	Year ended June 30,
	2015	2014	2013


Risk-free interest	1.39% - 2.06%	1.62% - 1.94%	0.74% - 1.00%
Dividend yields	0%	0%	0%
Volatility	46.5%-55.1%	46.3%-55.8%	55.8%-62.7%
Expected option term	5.50-6.27 years	6.02-6.27 years	6.08-6.27 years
Estimated forfeiture rate	12.5%-18.7%	14.0%	14.5%-20.9%

Stock Option [Member] | Non-employee consultants [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of assumptions used to estimate fair value of stock options and warrants

	Year ended June 30,
	2015	2014	2013


Risk-free interest	1.49%-2.58%	1.95%-2.45%	0.98%-1.96%
Dividend yields	0%	0%	0%
Volatility	45.5%-56.2%	45.0%-55.8%	55.8%-62.7%
Contractual life	7.2-10.0 years	6.0-10.0 years	7.0-10.0 years

PREPAID EXPENSES AND OTHER ACCOUNTS RECEIVABLE (Tables)

12 Months Ended

Jun. 30, 2015

PREPAID EXPENSES AND OTHER ACCOUNTS RECEIVABLE [Abstract]

Schedule of prepaid expenses and other accounts receivable

	June 30,
	2015		2014

Contract manufacturers(*)	$	24,814	$	10,234
Government authorities		3,729		646
OCS		249		-
Prepaid expenses and other		2,994		2,038
Foreign currency derivative contracts		859		213
Deferred charges (see Note 8)		-		20

	$	32,645	$	13,151

INVENTORIES (Tables)

12 Months Ended

Jun. 30, 2015

INVENTORIES [Abstract]

Schedule of inventories

	June 30,
	2015		2014


Raw materials	$	14,405	$	7,750
Finished goods		59,545		17,749

	$	73,950	$	25,499

PROPERTY AND EQUIPMENT (Tables)

12 Months Ended

Jun. 30, 2015

PROPERTY AND EQUIPMENT [Abstract]

Schedule of property and equipment

	June 30,
	2015		2014

Cost:

Computers and peripheral equipment	$	3,139	$	3,193
Office furniture and equipment		779		404
Laboratory and testing equipment		7,205		5,856
Machinery and equipment		6,936		2,491
Leasehold improvements		4,047		353
Vehicles		13		-

		22,119		12,297

Less - accumulated depreciation		7,402		6,946

Depreciated cost	$	14,717	$	5,351

ACCRUED EXPENSES AND OTHER ACCOUNTS PAYABLE (Tables)

12 Months Ended

Jun. 30, 2015

ACCRUED EXPENSES AND OTHER ACCOUNTS PAYABLE [Abstract]

Schedule of accrued expenses and other accounts payable

	June 30,
	2015		2014

Accrued expenses	$	5,271	$	2,807
Provision for contractual inventory purchase obligations *		1,304		1,317
OCS		-		146
Other		412		-

	$	6,987	$	4,270

* See also Note 10e.

WARRANTY OBLIGATIONS (Tables)

12 Months Ended

Jun. 30, 2015

WARRANTY OBLIGATIONS [Abstract]

Schedule of warranty obligations

	June 30,
	2015			2014

Balance, at beginning of year	$	18,181		$	10,378
Additions and adjustments to cost of revenues		19,407			11,861
Usage and current warranty expenses		(5,709	)		(4,058)

Balance, at end of year		31,879			18,181
Less current portion		(9,431	)		(5,496)

Long term portion	$	22,448		$	12,685

COMMITMENTS AND CONTINGENT LIABILITIES (Tables)

12 Months Ended

Jun. 30, 2015

COMMITMENTS AND CONTINGENT LIABILITIES [Abstract]

Schedule of future minimum lease commitments

2016	$	2,256
2017		2,218
2018		2,156
2019		2,042
2020 and thereafter		8,706

	$	17,378

CONVERTIBLE PREFERRED STOCK (Tables)

12 Months Ended

Jun. 30, 2015

CONVERTIBLE PREFERRED STOCK [Abstract]

Schedule of composition of convertible preferred stock

	Authorized			Issued and outstanding
		Number	of	shares
	June 30,
	2015	2014		2015	2014

Stock of $0.0001 par value:
Preferred stock	95,000,000	-		-	-
Series A Preferred stock	-	15,558,830		-	15,558,830
Series B Preferred stock	-	19,010,196		-	18,760,196
Series C Preferred stock	-	15,984,655		-	15,984,655
Series D Preferred stock	-	16,024,251		-	16,024,251
Series D-1 Preferred stock	-	5,100,000		-	2,165,441
Series D-2 Preferred stock (*)	-	2,598,528		-	2,598,528
Series D-3 Preferred stock	-	6,496,315		-	4,330,872
Series E Preferred stock(**)	-	-		-	-

	95,000,000	80,772,775		-	75,422,773

(*)	As of June 30, 2013, a total of $5,314 was received on account of preferred stock. The related 2,304,524 Series D-2 preferred stock were issued in July 2013.

(**)	In September 2014, the Company entered into a stock purchase agreement with new investors, pursuant to which the Company issued 9,321,019 shares of the Company's Series E Convertible Preferred stock for cash consideration of $25,000, which was received by the end of October 2014.

Schedule of convertible preferred stock outstanding prior to consummation of IPO

	Shares Outstanding	Number of Shares of Common Stock issued upon conversion

Series A Preferred stock	15,558,830	5,186,276
Series B Preferred stock	18,760,196	6,253,398
Series C Preferred stock	15,984,655	5,328,217
Series D Preferred stock	16,024,251	5,341,416
Series D-1 Preferred stock	2,165,441	721,813
Series D-2 Preferred stock	2,598,528	866,175
Series D-3 Preferred stock	4,330,872	1,443,623
Series E Preferred stock	9,321,019	3,107,005
	84,743,792	28,247,923

STOCK CAPITAL (Tables)

12 Months Ended

Jun. 30, 2015

STOCK CAPITAL [Abstract]

Schedule of composition of common stock capital

	Authorized		Issued and outstanding

	Number of shares
	June 30,		June 30,
	2015	2014	2015	2014

Stock of $0.0001 par value:
Common stock	125,000,000	34,939,461	39,297,539	2,809,950

Option [Member] | Employees and members of the board of directors [Member]

STOCK CAPITAL

Summary of the activity in the share options granted to employees and members of the board of directors

						Weighted
						average
				Weighted		remaining
	Number			average		contractual		Aggregate
	of			exercise		term		intrinsic
	options			price		in years		Value

Outstanding as of July 1, 2014		4,007,116		$	2.13		6.82	$	6,384
Granted		2,183,563		$	4.89
Exercised		(31,981	)	$	2.36
Forfeited or expired		(56,476	)	$	3.42
Outstanding as of June 30, 2015		6,102,222		$	3.10		7.08	$	202,889

Vested and expected to vest as of June 30, 2015		5,809,767		$	3.04		7.00	$	193,518

Exercisable as of June 30, 2015		3,551,239		$	2.17		5.71	$	121,373

						Weighted
						average
				Weighted		remaining
	Number			average		contractual		Aggregate
	of			exercise		term		intrinsic
	options			price		in years		Value

Outstanding as of July 1, 2013		3,625,366		$	1.92		7.39	$	5,757
Granted		575,457		$	3.41
Exercised		(27,459	)	$	1.86
Forfeited or expired		(166,248	)	$	2.16
Outstanding as of June 30, 2014		4,007,116		$	2.13		6.82	$	6,384

Vested and expected to vest as of June 30, 2014		3,746,620		$	2.07		6.69	$	6,175

Exercisable as of June 30, 2014		2,719,543		$	1.81		6.08	$	5,206

Schedule of exercise price range of options

	Options		Weighted		Options		Weighted
	outstanding		average		exercisable		average
Range of	as of		remaining		as of		remaining
exercise	June 30,		contractual		June 30,		contractual
price	2015		Life in years		2015		Life in years

$0.87		557,605		3.94		490,165		3.14
$1.50 - $1.68		771,321		4.04		771,321		4.04
$2.01 - $2.46		2,075,550		6.30		1,794,228		6.24
$3.03 - $3.96		668,270		8.54		247,767		8.46
$5.01 - $5.04		1,996,148		9.42		247,758		9.40
$9.36		33,328		9.59		-		-

		6,102,222		7.08		3,551,239		5.71

	Options		Weighted		Options		Weighted
	outstanding		average		exercisable		average
Range of	as of		remaining		as of		remaining
exercise	June 30,		contractual		June 30,		contractual
price	2014		Life in years		2014		Life in years

$0.87		490,165		4.14		490,165		4.14
$1.50 - $1.68		779,653		5.05		774,185		5.05
$2.01 - $2.46		2,114,517		7.31		1,388,628		7.19
$3.03 - $3.51		622,781		9.46		66,565		9.19

		4,007,116		6.82		2,719,543		6.08

Option [Member] | Non-employee consultants [Member]

STOCK CAPITAL

Summary of the activity in the share options granted to employees and members of the board of directors

	Options
	outstanding				Exercisable
	as of				as of
Issuance	June 30,		Exercise		June 30,		Exercisable
Date	2015		price		2015		Through

July 31, 2008		33,333	$	0.87		33,333	July 31, 2018
January 26, 2011		5,000	$	2.01		5,000	January 26, 2021
January 26, 2012		33,333	$	2.46		33,333	January 26, 2022
October 24, 2012		6,666	$	2.46		4,583	October 24, 2022
January 23, 2013		3,333	$	3.03		2,153	January 23, 2023
January 27, 2014		4,998	$	3.51		1,652	January 27, 2024
May 1, 2014		6,000	$	3.51		2,042	May 1, 2024
September 17, 2014		19,163	$	3.96		3,662	September 17, 2024
October 29, 2014		6,668	$	5.01		890	October 29, 2024

		118,494				86,648

	Options
	outstanding				Exercisable
	as of				as of
Issuance	June 30,		Exercise		June 30,		Exercisable
Date	2014		price		2014		Through

July 31, 2008		33,333	$	0.87		33,333	July 31, 2018
January 26, 2011		5,000	$	2.01		5,000	January 26, 2021
January 26, 2012		33,333	$	2.46		27,778	January 26, 2022
October 24, 2012		6,666	$	2.46		2,916	October 24, 2022
January 23, 2013		8,333	$	3.03		3,298	January 23, 2023
January 27, 2014		4,998	$	3.51		139	January 27, 2024
May 1, 2014		6,000	$	3.51		-	May 1, 2024

		97,663				72,464

Schedule of recognized stock-based compensation expenses

	Year ended June 30,
	2015		2014		2013

Cost of revenues	$	442	$	108	$	88
Research and development, net		635		397		381
Selling and marketing		809		297		317
General and administrative		1,070		280		292

Total stock-based compensation expense	$	2,956	$	1,082	$	1,078

- Definition

Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information. Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 480
-SubTopic 10
-Section S99
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=27011957&loc=d3e177068-122764

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21553-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(d),(e))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6403732&loc=d3e21300-112643

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21521-112644

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.28,29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21538-112644

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 30
-Article 5

+ Details

INCOME TAXES (Tables)

12 Months Ended

Jun. 30, 2015

INCOME TAXES [Abstract]

Schedule of deferred tax liabilities and assets

	June 30,
	2015			2014

Assets in respect of:

Carryforward tax losses (1)	$	23,033		$	32,203
Research and Development carryforward expenses- temporary differences		5,173			4,310
Other reserves		1,346			786

		29,552			37,299

Valuation allowance (2)		(29,552	)		(37,299	)

Net deferred tax assets	$	-		$	-

(1)	See Note 14c.

(2)

Schedule of income (loss) before taxes

	Year ended June 30,
	2015		2014

Domestic	$	2,830	$	661
Foreign		20,246		(21,819	)

	$	23,076	$	(21,158	)

Schedule of taxes on income

	Year ended June 30,
	2015		2014		2013

Federal	$	1,270	$	11	$	-
State		180		89		-
Foreign		300		120		108
Taxes on income related to prior years		205		-		-

	$	1,955	$	220	$	108

Schedule of reconciliation between the theoretical tax expense and the actual tax expense (benefit)

	Year ended June 30,
	2015			2014			2013


Income (loss) before taxes, as reported in the consolidated statements of operations	$	23,076		$	(21,158	)	$	(28,072	)

Statutory tax rate		35			35			35
Theoretical tax benefits on the above amount at the US statutory tax rate		8,077			(7,405	)		(9,825	)
Income tax at rate other than the U.S. statutory tax rate		(1,763	)		2,007			2,167
Impact of Israel corporate tax rate change from 25% to 26.5%		-			(2,103	)		-
Taxes on income related to prior years		205			-			-
Non-deductible expenses including equity based compensation expenses		3,003			467			300
Operating losses and other temporary differences for which valuation allowance was provided		(7,747	)		7,165			7,466
State tax		180			89			-

Actual tax expense	$	1,955		$	220		$	108

FINANCIAL EXPENSES (INCOME), NET (Tables)

12 Months Ended

Jun. 30, 2015

FINANCIAL EXPENSES (INCOME), NET [Abstract]

Schedule of financial expenses (income), net

	Year ended June 30,
	2015			2014			2013

Remeasurement of warrants to purchase convertible preferred stock	$	5,350		$	(53	)	$	40
Interest on term loan		579			1,475			794
Other financial expenses related to term loan		373			31			21
Expenses (income) related to hedging transaction		(1,721	)		189			(207	)
Interest on short- term loan		316			537			276
Exchange rate loss (income), net, bank charges and other finance expenses		180			608			(312	)

	$	5,077		$	2,787		$	612

GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Tables)

12 Months Ended

Jun. 30, 2015

GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA [Abstract]

Summary of revenues within geographic areas

	Year ended June 30,
	2015		2014		2013

Revenues based on Customers' location:
United States	$	238,340	$	64,607	$	15,334
Germany		13,290		15,133		12,692
Europe (*)		52,163		38,655		40,367
Rest of the World		21,285		14,822		10,642
Total revenues	$	325,078	$	133,217	$	79,035

(*)	Except for Germany

Schedule of major customers data as percentage of total revenues

Year ended
June 30,

2015

2014

2013

Customer A

24.6%

19.1%

*)	Less than 10%.

Summary of revenues by product family

	Year ended June 30,
	2015		2014		2013

Inverters	$	156,984	$	62,085	$	35,422
Optimizers		158,513		65,018		38,337
Others		9,581		6,114		5,276
Total revenues	$	325,078	$	133,217	$	79,035

Schedule of long-lived assets by geographic region

	Year ended June 30,
	2015		2014

Israel	$	14,136	$	5,025
Europe		230		211
U.S.		342		112
Other		9		3

Total long-lived assets*	$	14,717	$	5,351

*	Long-lived assets are comprised of property and equipment, net (long term lease deposits and severance pay fund are not included).

GENERAL (Details) $ in Thousands				12 Months Ended
GENERAL (Details) $ in Thousands	Jun. 30, 2015	Mar. 31, 2015 USD ($) shares	Jun. 30, 2014	Jun. 30, 2015 item	Jun. 30, 2014	Jun. 17, 2015 shares
General [Line Items]
Number of shares of common stock sold to the public		8,050,000
Number of shares of common stock sold pursuant to the full exercise of an overallotment option granted to the underwriters		1,050,000
Aggregate net proceeds received from offerings \| $		$ 131,208
Convertible preferred stock converted into number of shares of common stock		28,247,923
Warrants to purchase number of shares of common stock		187,671				187,671
Number of contract manufacturers \| item				2
Number of vendors \| item				2
Consolidated revenues [Member] \| Major customer [Member]
General [Line Items]
Percentage of customer revenue	24.60%		19.10%
Trade payables [Member] \| Lender [Member]
General [Line Items]
Percentage of customer revenue				79.00%	60.00%

SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details) - USD ($) $ in Thousands		12 Months Ended
	Apr. 12, 2009	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
Financial statements in U.S. dollars
Accumulated other comprehensive loss related to foreign currency translation adjustments, net		$ 222	$ 61	$ 26
Basic and Diluted Net Earnings (Loss) Per Share
Total weighted average number of shares related to the outstanding stock options, convertible preferred stock and warrants to purchase convertible preferred stock, excluded from the calculation of diluted net earnings (loss) per share due to their anti-dilutive effect		20,565,747	25,234,818	22,953,263
Impairment of long-lived assets
Impairment losses		$ 0	$ 0	$ 0
Severance pay
Severance expenses		$ 1,273	1,109	974
Revenue recognition
Estimated service period		25 years
Shipping and handling costs
Shipping and handling costs		$ 26,931	14,066	5,140
Warranty obligations
Minimum term of warranty obligations for inverters		12 years
Minimum term of warranty obligations for power optimizers		25 years
Maximum extended product warranty period		25 years
Royalty bearing grant
Amount received as royalty grant	$ 703			$ 248
Government grants
Government grants received		$ 763	$ 275

SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
Numerator:
Net income (loss)	$ 21,121	$ (21,378)	$ (28,180)
Dividends accumulated for the period	(17,550)
Net income (loss) available to shareholders of common stock	$ 3,571	$ (21,378)	$ (28,180)
Denominator:
Shares used in computing net earnings (loss) per share of common stock, basic (in shares)	11,902,911	2,798,894	2,741,370
Numerator:
Net income (loss)	$ 21,121	$ (21,378)	$ (28,180)
Dividends accumulated for the period	(16,971)
Net income (loss) available to shareholders of common stock	$ 4,150	$ (21,378)	$ (28,180)
Denominator:
Shares used in computing net earnings (loss) per share of common stock, diluted (in shares)	15,269,448	2,798,894	2,741,370

SIGNIFICANT ACCOUNTING POLICIES (Estimated Useful Lives of Property and Equipment) (Details)	12 Months Ended
	Jun. 30, 2015
Computer and peripheral equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, depreciation rate	33.00%
Computer and peripheral equipment [Member] \| Minimum [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, depreciation rate	14.00%
Computer and peripheral equipment [Member] \| Maximum [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, depreciation rate	33.00%
Office furniture and equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, depreciation rate	7.00%
Office furniture and equipment [Member] \| Minimum [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, depreciation rate	7.00%
Office furniture and equipment [Member] \| Maximum [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, depreciation rate	15.00%
Machinery & equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, depreciation rate	20.00%
Machinery & equipment [Member] \| Minimum [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, depreciation rate	7.00%
Machinery & equipment [Member] \| Maximum [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, depreciation rate	33.00%
Laboratory equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, depreciation rate	15.00%
Laboratory equipment [Member] \| Minimum [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, depreciation rate	15.00%
Laboratory equipment [Member] \| Maximum [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, depreciation rate	33.00%
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, depreciation rate	15.00%
Leasehold improvements [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives of assets	<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';">over the shorter of the lease term or useful economic life</div>

SIGNIFICANT ACCOUNTING POLICIES (Concentrations of Credit risks) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
Concentration Risk [Line Items]
Accrued allowance for doubtful accounts	$ 13
Derivative financial instruments
Fair value of derivative instruments	$ 859	$ 213	$ 258
Trade receivables [Member] \| Customer [Member]
Concentration Risk [Line Items]
Percentage of customer revenue	30.00%	31.00%

SIGNIFICANT ACCOUNTING POLICIES (Estimate Fair Value of Stock Options and Warrants) (Details)	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
Warrants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Volatility rate		45.00%	55.80%
Risk-free rate		0.09%	0.30%
Dividend yield		0.00%	0.00%
Expected term (in years)		1 year 2 months 16 days	1 year 6 months
Stock Option [Member] \| Employee and Executive Director [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Minimum volatility rate	46.50%	46.30%	55.80%
Maximum volatility rate	55.10%	55.80%	62.70%
Risk-free rate minimum	1.39%	1.62%	0.74%
Risk-free rate maximum	2.06%	1.94%	1.00%
Dividend yield	0.00%	0.00%	0.00%
Estimated forfeiture rate		14.00%
Stock Option [Member] \| Employee and Executive Director [Member] \| Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	5 years 6 months	6 years 7 days	6 years 29 days
Estimated forfeiture rate	12.50%		14.50%
Stock Option [Member] \| Employee and Executive Director [Member] \| Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	6 years 3 months 7 days	6 years 3 months 7 days	6 years 3 months 7 days
Estimated forfeiture rate	18.70%		20.90%
Stock Option [Member] \| Non-employee Consultants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Minimum volatility rate	45.50%	45.00%	55.80%
Maximum volatility rate	56.20%	55.80%	62.70%
Risk-free rate minimum	1.49%	1.95%	0.98%
Risk-free rate maximum	2.58%	2.45%	1.96%
Dividend yield	0.00%	0.00%	0.00%
Stock Option [Member] \| Non-employee Consultants [Member] \| Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	7 years 2 months 12 days	6 years	7 years
Stock Option [Member] \| Non-employee Consultants [Member] \| Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	10 years	10 years	10 years

SIGNIFICANT ACCOUNTING POLICIES (Schedule of Change in Fair Value of Warrants) (Details) - USD ($)
$ in Thousands

12 Months Ended

Jun. 30, 2015

Jun. 30, 2014

Jun. 30, 2013

Jun. 17, 2015

Mar. 31, 2015

Change in fair value of warrants to purchase convertible preferred stock

Balance at beginning of period

$ 765

$ 818

Issuance of warrants to purchase preferred stock

778

Exercise of warrants to purchase preferred stock

^[1]

(6,115)

Change in fair value

5,350

(53)

Balance at end of period

$ 765

$ 818

Warrants to purchase number of shares of common stock

187,671

Cashless warrants exercised into common shares

154,768

[1]	Upon the closing of the IPO, all outstanding warrants to purchase convertible preferred stock automatically converted into warrants to purchase 187,671 shares of common stock (See Note 1b).

PREPAID EXPENSES AND OTHER ACCOUNTS RECEIVABLE (Details) - USD ($)
$ in Thousands

Jun. 30, 2015

Jun. 30, 2014

Jun. 30, 2013

PREPAID EXPENSES AND OTHER ACCOUNTS RECEIVABLE [Abstract]

Contract manufacturers

^[1]

$ 24,814

$ 10,234

Government authorities

3,729

646

OCS

249

Prepaid expenses and other

2,994

2,038

Foreign currency derivative contracts

859

213

$ 258

Deferred charges (see Note 8)

Prepaid expenses and other accounts receivable

32,645

13,151

Foreign currency derivative contracts

$ 859

$ 213

[1]	Contract manufacturers receivables derive from the sale of components to manufacturing vendors who manufacture products for the Company. The Company purchases these components directly from suppliers. The Company does not reflect the sale of these components in revenues (see also Note 10e).

INVENTORIES (Details) - USD ($) $ in Thousands	12 Months Ended
INVENTORIES (Details) - USD ($) $ in Thousands	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
INVENTORIES [Abstract]
Raw materials	$ 14,405	$ 7,750
Finished goods	59,545	17,749
Inventories	73,950	25,499
Write-down amount of inventory	$ 992	$ 1,131	$ 428

PROPERTY AND EQUIPMENT (Details) - USD ($)
$ in Thousands

12 Months Ended

Jun. 30, 2015

Jun. 30, 2014

Jun. 30, 2013

Less - accumulated depreciation

$ 22,119

$ 12,297

7,402

6,946

Depreciated cost

^[1]

14,717

5,351

Depreciation expenses

2,253

1,978

$ 1,842

Computers and peripheral equipment [Member]

Office furniture and equipment [Member]

3,139

3,193

Laboratory and testing equipment [Member]

779

404

Machinery and equipment [Member]

7,205

5,856

Leasehold improvements [Member]

6,936

2,491

4,047

353

Vehicles [Member]

ACCRUED EXPENSES AND OTHER ACCOUNTS PAYABLE [Abstract]

$ 13

[1]	Long-lived assets are comprised of property and equipment, net (long term lease deposits and severance pay fund are not included).

ACCRUED EXPENSES AND OTHER ACCOUNTS PAYABLE (Details) - USD ($)
$ in Thousands

Jun. 30, 2015

Jun. 30, 2014

Accrued expenses

$ 5,271

$ 2,807

Provision for contractual inventory purchase obligations

^[1]

1,304

1,317

OCS

146

Other

412

Accrued expenses and other accounts payable

$ 6,987

$ 4,270

[1]	* See also Note 10e.

WARRANTY OBLIGATIONS (Details) - USD ($) $ in Thousands	12 Months Ended
WARRANTY OBLIGATIONS (Details) - USD ($) $ in Thousands	Jun. 30, 2015	Jun. 30, 2014
Changes in the Company's product warranty liability
Balance, at beginning of year	$ 18,181	$ 10,378
Additions and adjustments to cost of revenues	19,407	11,861
Usage and current warranty expenses	(5,709)	(4,058)
Balance, at end of year	31,879	18,181
Less current portion	(9,431)	(5,496)
Long term portion	$ 22,448	$ 12,685

TERM LOAN AND WARRANTS TO PURCHASE CONVERTIBLE PREFERRED STOCK (Details) $ / shares in Units, $ in Thousands		12 Months Ended
	Dec. 28, 2012 USD ($) item $ / shares shares	Jun. 30, 2015 USD ($) shares	Jun. 30, 2014 USD ($)	Jun. 30, 2013 USD ($)	Jun. 17, 2015 shares	Mar. 31, 2015 shares
TERM LOAN AND WARRANTS TO PURCHASE CONVERTIBLE PREFERRED STOCK [Line Items]
Proceeds from loans				$ 9,900
Loan transaction fee paid				$ 100
Warrants granted to lender \| shares					187,671	187,671
Cashless warrants exercised into common shares \| shares		154,768
Fair value of the Warrants liability reclassified to stockholders' equity		$ 6,115
Term loan [Member]
TERM LOAN AND WARRANTS TO PURCHASE CONVERTIBLE PREFERRED STOCK [Line Items]
Loan amount	$ 10,000
Proceeds from loans	10,000
Loan transaction fee paid	$ 100
Debt instrument maturity period	42 months
Interest rate (as a percent)	11.90%
Number of monthly payments in which principal of loan to be paid \| item	33
Warrant intrinsic value threshold	$ 750
Warrant liability at fair value	778		$ 765
Residual amount	9,122
Issuance expense allocated to the warrants liability and to the loan	75
Issuance expenses related to the Warrants liability immediately expensed and recorded as financial expenses, net	6
Issuance expenses related to the Loan recorded as deferred charge assets	$ 69
Term loan [Member] \| Series D-1 convertible preferred stock [Member]
TERM LOAN AND WARRANTS TO PURCHASE CONVERTIBLE PREFERRED STOCK [Line Items]
Warrants granted to lender \| shares	563,014
Exercise price of warrants (in dollars per share) \| $ / shares	$ 2.309
Period after a qualified initial public offering considered while deciding warrants exercisability	12 months

REVOLVING CREDIT LINE (Details) - Revolving line of credit [Member] - USD ($) $ in Thousands	1 Months Ended		12 Months Ended
	Feb. 28, 2015	Jun. 30, 2011	Jun. 30, 2015	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2014
REVOLVING CREDIT LINE [Line Items]
Aggregate borrowings	$ 40,000	$ 20,000
Maximum specified percentage of eligible trade receivables considered for determining maximum borrowing capacity	80.00%	80.00%
Maximum specified percentage of inventories in transit considered for determining maximum borrowing capacity		65.00%
Description of variable rate basis	<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';">Bank Lender's prime rate</div>		<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';">Bank Lender's prime rate</div>
Average interest rate (as a percent)							4.90%
Termination date	Dec. 31, 2016
Maximum non-cash stock-based compensation considered calculation of net income	$ (1,500)
Minimum positive Adjusted EBITDA as of June 30, 2015			$ 1,500
Minimum positive Adjusted EBITDA quarterly				$ 1,500	$ 3,500	$ 3,500
Minimum positive Adjusted EBITDA as of June 30, 2016			3,500
Amount of liquidity need to maintain	$ 6,750
Outstanding borrowings			$ 0
Minimum [Member]
REVOLVING CREDIT LINE [Line Items]
Applicable margin (as a percent)	0.50%		0.75%
Maximum [Member]
REVOLVING CREDIT LINE [Line Items]
Applicable margin (as a percent)	2.00%		2.75%

COMMITMENTS AND CONTINGENT LIABILITIES (Schedule of Future Minimum Lease Commitments) (Details) $ in Thousands	Jun. 30, 2015 USD ($)
Future minimum lease commitments
2016	$ 2,256
2017	2,218
2018	2,156
2019	2,042
2020 and thereafter	8,706
Future minimum lease commitments amount	$ 17,378

COMMITMENTS AND CONTINGENT LIABILITIES (Narrative) (Lease commitments, Guarantees, Royalty commitments, Governmental commitments, Contractual purchase obligations) (Details) - USD ($)
$ in Thousands

12 Months Ended

Apr. 12, 2009

Jun. 30, 2015

Jun. 30, 2014

Jun. 30, 2013

Lease commitments

Contract term

10 years

Rent expenses

$ 1,714

$ 1,200

$ 1,212

Royalty commitments

Amount received as royalty grant

$ 703

$ 248

Royalties payment percentage of gross sales of products developed with funds provided by the BIRD-F

5.00%

Royalties payment subject to maximum percentage of research and development grants

150.00%

Aggregate contingent liability to the BIRD-F amount

$ 1,135

Governmental commitments

Royalties payment percentage to OCS for first three years

4.00%

Royalties percentage of 4% for number of years

3 years

Royalties payment percentage to OCS for thereafter years

4.50%

Maximum royalties percentage of grants received

100.00%

Governmental commitments amount

$ 771

Royalties payables

Contractual purchase obligations

Non-cancelable purchase obligations

92,071

Provision for contractual inventory purchase obligations

^[1]

1,304

$ 1,317

Office rent lease agreements [Member]

Guarantees [line Items]

Guarantees amount

813

Customs transactions [Member]

Guarantees [line Items]

Guarantees amount

Credit card limits [Member]

Guarantees [line Items]

Guarantees amount

$ 85

[1]	* See also Note 10e.

COMMITMENTS AND CONTINGENT LIABILITIES (Narrative) (Legal claims) (Details) - Appletech [Member] $ in Thousands	Jul. 24, 2014 USD ($)	Jul. 24, 2014 ILS (₪)	Jun. 30, 2014 USD ($)	Jun. 30, 2014 ILS (₪)
Legal claims [Line Items]
Loss contingency accrual amount			$ 642	₪ 2,208,000
Payment made to plaintiff	$ 502	₪ 1,725,000
Maximum payment period	45 days	45 days

LEASE INCENTIVE OBLIGATION (Details) $ in Thousands	Jun. 30, 2015 USD ($)
LEASE INCENTIVE OBLIGATION [Abstract]
Operating lease receivable	$ 2,811
Received in cash from the Lessor	$ 2,313

CONVERTIBLE PREFERRED STOCK (Composition of Convertible Preferred Stock) (Details) - $ / shares

Jun. 30, 2015

Jun. 30, 2014

95,000,000

80,772,775

75,422,773

75,422,773

$ 0.0001

Preferred stock [Member]

95,000,000

Series A Preferred stock [Member]

15,558,830

15,558,830

15,558,830

Series B Preferred stock [Member]

$ 0.0001

19,010,196

18,760,196

18,760,196

Series C Preferred stock [Member]

$ 0.0001

15,984,655

15,984,655

15,984,655

Series D Preferred stock [Member]

$ 0.0001

16,024,251

16,024,251

16,024,251

Series D-1 Preferred stock [Member]

$ 0.0001

5,100,000

2,165,441

2,165,441

Series D-2 Preferred stock [Member]

$ 0.0001

^[1]

2,598,528

^[1]

2,598,528

^[1]

2,598,528

Series D-3 Preferred stock [Member]

$ 0.0001

6,496,315

4,330,872

4,330,872

Series E Preferred stock [Member]

$ 0.0001

^[2]

^[2]

Research and Development carryforward expenses- temporary differences

^[2]

[1]	As of June 30, 2013, a total of $5,314 was received on account of preferred stock. The related 2,304,524 Series D-2 preferred stock were issued in July 2013.
[2]	In September 2014, the Company entered into a stock purchase agreement with new investors, pursuant to which the Company issued 9,321,019 shares of the Company's Series E Convertible Preferred stock for cash consideration of $25,000, which was received by the end of October 2014.

CONVERTIBLE PREFERRED STOCK (Narrative) (Details) - USD ($) $ in Thousands	1 Months Ended			12 Months Ended
	Mar. 31, 2015	Sep. 30, 2014	Jul. 31, 2013	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
Convertible Preferred Stock [Line Items]
Amount received on account of preferred stock						$ 5,314
Classification of convertible preferred stock temporary equity into stockholders' equity (deficiency)	$ 140,915
Series D-2 Preferred stock [Member]
Convertible Preferred Stock [Line Items]
Amount received on account of preferred stock						$ 5,314
Stock issued for cash consideration (in shares)			2,304,524
Stock issued for cash consideration
Series E Preferred stock [Member]
Convertible Preferred Stock [Line Items]
Stock issued for cash consideration (in shares)		9,321,019
Stock issued for cash consideration		$ 25,000

CONVERTIBLE PREFERRED STOCK (Schedule of convertible preferred stock outstanding prior to consummation of IPO) (Details)	12 Months Ended
	Jun. 30, 2015 shares
Convertible Preferred Stock [Line Items]
Shares Outstanding	84,743,792
Number of Shares of Common Stock issued upon conversion	28,247,923
Series A Preferred stock [Member]
Convertible Preferred Stock [Line Items]
Shares Outstanding	15,558,830
Number of Shares of Common Stock issued upon conversion	5,186,276
Series B Preferred stock [Member]
Convertible Preferred Stock [Line Items]
Shares Outstanding	18,760,196
Number of Shares of Common Stock issued upon conversion	6,253,398
Series C Preferred stock [Member]
Convertible Preferred Stock [Line Items]
Shares Outstanding	15,984,655
Number of Shares of Common Stock issued upon conversion	5,328,217
Series D Preferred stock [Member]
Convertible Preferred Stock [Line Items]
Shares Outstanding	16,024,251
Number of Shares of Common Stock issued upon conversion	5,341,416
Series D-1 Preferred stock [Member]
Convertible Preferred Stock [Line Items]
Shares Outstanding	2,165,441
Number of Shares of Common Stock issued upon conversion	721,813
Series D-2 Preferred stock [Member]
Convertible Preferred Stock [Line Items]
Shares Outstanding	2,598,528
Number of Shares of Common Stock issued upon conversion	866,175
Series D-3 Preferred stock [Member]
Convertible Preferred Stock [Line Items]
Shares Outstanding	4,330,872
Number of Shares of Common Stock issued upon conversion	1,443,623
Series E Preferred stock [Member]
Convertible Preferred Stock [Line Items]
Shares Outstanding	9,321,019
Number of Shares of Common Stock issued upon conversion	3,107,005

STOCK CAPITAL (Common Stock) (Details)	12 Months Ended
STOCK CAPITAL (Common Stock) (Details)	Jun. 30, 2015 item $ / shares shares	Jun. 30, 2014 $ / shares shares
STOCK CAPITAL [Abstract]
Reverse stock split ratio	3
Common stock capital
Par value \| $ / shares	$ 0.0001	$ 0.0001
Authorized	125,000,000	34,939,461
Common stock, issued shares	39,297,539	2,809,950
Common stock, outstanding shares	39,297,539	2,809,950
Number of votes per share \| item	1

STOCK CAPITAL (Stock option plans) (Details) - USD ($) $ / shares in Units, $ in Thousands		12 Months Ended
	Dec. 31, 2014	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
Stock option plans
Number of shares of common stock reserved for issuance pursuant to stock awards under the plan		10,000,000
Employees and members of the board of directors [Member] \| Maximum [Member] \| 2015 Plan
Stock option plans
Percentage of common shares increase automatically in each year	5.00%
Option [Member]
Stock option plans
Number of options are available for future grant under the plan		379,358
Unrecognized compensation expense		$ 10,577
Option [Member] \| 2015 Plan
Stock option plans
Number of shares of common stock reserved for issuance pursuant to stock awards under the plan		1,822,484
Number of options are available for future grant under the plan		1,755,044
Percentage of common shares increase automatically in each year		5.00%
Option [Member] \| Employees and members of the board of directors [Member]
Stock option plans
Intrinsic value of options exercised		$ 484	$ 58
Weighted average grant date fair values options granted to employees and executive directors		$ 7.57	$ 0.66	$ 0.52
ESPP [Member]
Stock option plans
Number of shares of common stock reserved for issuance pursuant to stock awards under the plan		487,643
Period of plan increase automatically number of shares		10 years
Percentage of common shares increase automatically in each year		1.00%

STOCK CAPITAL (Summary of the activity in the share options) (Details) - Option [Member] - Employees and members of the board of directors [Member] - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
Number of options
Outstanding at the beginning of the period	4,007,116	3,625,366
Granted	2,183,563	575,457
Exercised	(31,981)	(27,459)
Forfeited or expired	(56,476)	(166,248)
Outstanding at the end of the period	6,102,222	4,007,116	3,625,366
Weighted average exercise price
Outstanding at the beginning of the period	$ 2.13	$ 1.92
Granted	4.89	3.41
Exercised	2.36	1.86
Forfeited or expired	3.42	2.16
Outstanding at the end of the period	$ 3.10	$ 2.13	$ 1.92
Weighted average remaining contractual term in years
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	7 years 29 days	6 years 9 months 25 days	7 years 4 months 20 days
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	7 years 29 days	6 years 9 months 25 days	7 years 4 months 20 days
Aggregate intrinsic Value
Outstanding at the beginning of the period	$ 6,384	$ 5,757
Outstanding at the end of the period	$ 202,889	$ 6,384	$ 5,757
Vested and expected to vest at the end of the period
Number of options	5,809,767	3,746,620
Weighted average exercise price	$ 3.04	$ 2.07
Weighted average remaining contractual term in years	7 years	6 years 8 months 8 days
Aggregate intrinsic Value	$ 193,518	$ 6,175
Exercisable at the end of the period
Number of options	3,551,239	2,719,543
Weighted average exercise price	$ 2.17	$ 1.81
Weighted average remaining contractual term in years	5 years 8 months 16 days	6 years 29 days
Aggregate intrinsic Value	$ 121,373	$ 5,206

STOCK CAPITAL (Schedule of exercise price ranges) (Details) - Employees and members of the board of directors [Member] - $ / shares	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Range of exercise price [Line Items]
Options outstanding	6,102,222	4,007,116
Weighted average remaining contractual Life in years	7 years 29 days	6 years 9 months 25 days
Options exercisable	3,551,239	2,719,543
Weighted average remaining contractual Life in years	5 years 8 months 16 days	6 years 29 days
$0.87 [Member]
Range of exercise price [Line Items]
Exercise price	$ 0.87	$ 0.87
Options outstanding	557,605	490,165
Weighted average remaining contractual Life in years	3 years 11 months 8 days	4 years 1 month 20 days
Options exercisable	490,165	490,165
Weighted average remaining contractual Life in years	3 years 1 month 20 days	4 years 1 month 20 days
$1.50 - $1.68 [Member]
Range of exercise price [Line Items]
Range of exercise price, lower	$ 1.50	$ 1.50
Range of exercise price, upper	$ 1.68	$ 1.68
Options outstanding	771,321	779,653
Weighted average remaining contractual Life in years	4 years 14 days	5 years 18 days
Options exercisable	771,321	774,185
Weighted average remaining contractual Life in years	4 years 14 days	5 years 18 days
$2.01 - $2.46 [Member]
Range of exercise price [Line Items]
Range of exercise price, lower	$ 2.01	$ 2.01
Range of exercise price, upper	$ 2.46	$ 2.46
Options outstanding	2,075,550	2,114,517
Weighted average remaining contractual Life in years	6 years 3 months 18 days	7 years 3 months 22 days
Options exercisable	1,794,228	1,388,628
Weighted average remaining contractual Life in years	6 years 2 months 26 days	7 years 2 months 8 days
$3.03 - $3.51 [Member]
Range of exercise price [Line Items]
Range of exercise price, lower		$ 3.03
Range of exercise price, upper		$ 3.51
Options outstanding		622,781
Weighted average remaining contractual Life in years		9 years 5 months 16 days
Options exercisable		66,565
Weighted average remaining contractual Life in years		9 years 2 months 8 days
$3.03 - $3.96 [Member]
Range of exercise price [Line Items]
Range of exercise price, lower	$ 3.03
Range of exercise price, upper	$ 3.96
Options outstanding	668,270
Weighted average remaining contractual Life in years	8 years 6 months 14 days
Options exercisable	247,767
Weighted average remaining contractual Life in years	8 years 5 months 16 days
$5.01 - $5.04 [Member]
Range of exercise price [Line Items]
Range of exercise price, lower	$ 5.01
Range of exercise price, upper	$ 5.04
Options outstanding	1,996,148
Weighted average remaining contractual Life in years	9 years 5 months 1 day
Options exercisable	247,758
Weighted average remaining contractual Life in years	9 years 4 months 24 days
$9.36 [Member]
Range of exercise price [Line Items]
Exercise price	$ 9.36
Options outstanding	33,328
Weighted average remaining contractual Life in years	9 years 7 months 2 days
Options exercisable
Weighted average remaining contractual Life in years

STOCK CAPITAL (Options issued to non-employee consultants) (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
Stock option plans
Stock compensation expenses	$ 2,956	$ 1,082	$ 1,078
Option [Member] \| Non-employee consultants [Member]
Stock option plans
Options outstanding at the end of the period	118,494	97,663
Exercisable at the end of the period	86,648	72,464
Stock compensation expenses	$ 563	$ 55	$ 45
Option [Member] \| Non-employee consultants [Member] \| July 31, 2008
Stock option plans
Options outstanding at the end of the period	33,333	33,333
Exercise price	$ 0.87	$ 0.87
Exercisable at the end of the period	33,333	33,333
Option [Member] \| Non-employee consultants [Member] \| January 26, 2011
Stock option plans
Options outstanding at the end of the period	5,000	5,000
Exercise price	$ 2.01	$ 2.01
Exercisable at the end of the period	5,000	5,000
Option [Member] \| Non-employee consultants [Member] \| January 26, 2012
Stock option plans
Options outstanding at the end of the period	33,333	33,333
Exercise price	$ 2.46	$ 2.46
Exercisable at the end of the period	33,333	27,778
Option [Member] \| Non-employee consultants [Member] \| October 24, 2012
Stock option plans
Options outstanding at the end of the period	6,666	6,666
Exercise price	$ 2.46	$ 2.46
Exercisable at the end of the period	4,583	2,916
Option [Member] \| Non-employee consultants [Member] \| January 23, 2013
Stock option plans
Options outstanding at the end of the period	3,333	8,333
Exercise price	$ 3.03	$ 3.03
Exercisable at the end of the period	2,153	3,298
Option [Member] \| Non-employee consultants [Member] \| January 27, 2014
Stock option plans
Options outstanding at the end of the period	4,998	4,998
Exercise price	$ 3.51	$ 3.51
Exercisable at the end of the period	1,652	139
Option [Member] \| Non-employee consultants [Member] \| May 1, 2014
Stock option plans
Options outstanding at the end of the period	6,000	6,000
Exercise price	$ 3.51	$ 3.51
Exercisable at the end of the period	2,042
Option [Member] \| Non-employee consultants [Member] \| September 17, 2014
Stock option plans
Options outstanding at the end of the period	19,163
Exercise price	$ 3.96
Exercisable at the end of the period	3,662
Option [Member] \| Non-employee consultants [Member] \| October 29, 2014
Stock option plans
Options outstanding at the end of the period	6,668
Exercise price	$ 5.01
Exercisable at the end of the period	890

STOCK CAPITAL (Schedule of stock-based compensation expense for employees and non-employee consultants) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
Stock-based compensation expenses
Total stock-based compensation expense	$ 2,956	$ 1,082	$ 1,078
Cost of revenues [Member]
Stock-based compensation expenses
Total stock-based compensation expense	442	108	88
Research and development, net [Member]
Stock-based compensation expenses
Total stock-based compensation expense	635	397	381
Selling and marketing [Member]
Stock-based compensation expenses
Total stock-based compensation expense	809	297	317
General and administrative [Member]
Stock-based compensation expenses
Total stock-based compensation expense	$ 1,070	$ 280	$ 292

INCOME TAXES (Narratives) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
INCOME TAXES [Line Items]
Corporate tax rate (as a percent)	35.00%	35.00%	35.00%
Net carryforward tax losses
Germany [Member] \| Subsidiaries [Member]
INCOME TAXES [Line Items]
Corporate tax rate (as a percent)	33.00%
Israel [Member] \| Subsidiaries [Member]
INCOME TAXES [Line Items]
Corporate tax rate (as a percent)	26.50%	26.50%	25.00%
Net carryforward tax losses	$ 84,700
Amortization period for patents and know-how for industrial company	8 years
Amortization period for deferred expenses related to public offering for industrial company	3 years
Israel [Member] \| Subsidiaries [Member] \| Beneficiary Enterprise [Member]
INCOME TAXES [Line Items]
Period for which productive activity will be exempt from tax under Investment Law				2 years
Period from beginning of the year of election for which tax benefit is available under Investment Law				12 years
Dividend tax rate (as a percent)				15.00%
Israel [Member] \| Subsidiaries [Member] \| Preferred Enterprise [Member]
INCOME TAXES [Line Items]
Corporate tax rate (as a percent)		16.00%
Dividend tax rate (as a percent)	20.00%
California [Member]
INCOME TAXES [Line Items]
Net carryforward tax losses	$ 9,794
Expiration date of tax carryforward	Jan. 01, 2031

INCOME TAXES (Schedule of Deferred Tax Liabilities And Assets) (Details) - USD ($)
$ in Thousands

Jun. 30, 2015

Jun. 30, 2014

Assets in respect of:

Carryforward tax losses

^[1]

$ 23,033

$ 32,203

5,173

4,310

Other reserves

1,346

786

Deferred tax assets, gross

29,552

37,299

Valuation allowance

^[2]

29,552

37,299

Net deferred tax assets

[1]	See Note 14c.
[2]	The Company has provided full valuation allowances as of June 30, 2015 and 2014 on deferred tax assets resulting from carryforward tax losses, research and development carryforward expenses and other reserves due to its history of operating losses and current uncertainty concerning the ability to realize these deferred tax assets in the future.

INCOME TAXES (Schedule of Income (Loss) Before Taxes) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
INCOME TAXES [Abstract]
Domestic	$ (2,830)	$ (661)
Foreign	(20,246)	21,819
Income (loss) before taxes on income	$ 23,076	$ (21,158)	$ (28,072)

INCOME TAXES (Schedule of Taxes on Income) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
INCOME TAXES [Abstract]
Federal	$ 1,270	$ 11
State	180	89
Foreign	300	120	108
Taxes on income related to prior years	205
Taxes on loss	$ 1,955	$ 220	$ 108

INCOME TAXES (Schedule of reconciliation between the theoretical tax expense and the actual tax expense (benefit)) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
INCOME TAXES [Abstract]
Income (loss) before taxes, as reported in the consolidated statements of operations	$ 23,076	$ (21,158)	$ (28,072)
Statutory tax rate (as a percent)	35.00%	35.00%	35.00%
Theoretical tax benefits on the above amount at the US statutory tax rate	$ 8,077	$ (7,405)	$ (9,825)
Income tax at rate other than the U.S. statutory tax rate	(1,763)	2,007	2,167
Impact of Israel corporate tax rate change from 25% to 26.5%		(2,103)
Taxes on income related to prior years	205
Non-deductible expenses including equity based compensation expenses	3,003	467	300
Operating losses and other temporary differences for which valuation allowance was provided	(7,747)	7,165	7,466
State tax	180	89
Actual tax expense	$ 1,955	$ 220	$ 108

FINANCIAL EXPENSES (INCOME), NET (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
FINANCIAL EXPENSES (INCOME), NET [Abstract]
Remeasurement of warrants to purchase convertible preferred stock	$ 5,350	$ (53)	$ 40
Interest on term loan	579	1,475	794
Other financial expenses related to term loan	373	31	21
Expenses (income) related to hedging transaction	(1,721)	189	(207)
Interest on short-term loan	316	537	276
Exchange rate loss (income), net, bank charges and other finance expenses	180	608	(312)
Financial expenses (income), net	$ 5,077	$ 2,787	$ 612

GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Summary of Revenues Within Geographic Areas) (Details)
$ in Thousands

12 Months Ended

Jun. 30, 2015

USD ($)

item

Jun. 30, 2014

USD ($)

Jun. 30, 2013

USD ($)

GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA [Abstract]

Number of reportable segments | item

$ 325,078

$ 133,217

$ 79,035

United States [Member]

238,340

64,607

15,334

Germany [Member]

13,290

15,133

12,692

Europe [Member]

Rest of the World [Member]

^[1]

52,163

38,655

40,367

Revenues [Member] | Major customer [Member] | Customer A [Member]

$ 21,285

$ 14,822

$ 10,642

[1]	Except for Germany

GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Schedule of Major Customers Data As a Percentage of Total Revenues) (Details)

12 Months Ended

Jun. 30, 2015

Jun. 30, 2014

Jun. 30, 2013

Revenue, Major Customer [Line Items]

Percentage of customer revenue

24.60%

19.10%

^[1]

[1]	Less than 10%.

GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Summary of Revenues by Product Family) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
Revenues by product family [Line Items]
Total revenues	$ 325,078	$ 133,217	$ 79,035
Inverters [Member]
Revenues by product family [Line Items]
Total revenues	156,984	62,085	35,422
Optimizers [Member]
Revenues by product family [Line Items]
Total revenues	158,513	65,018	38,337
Others [Member]
Revenues by product family [Line Items]
Total revenues	$ 9,581	$ 6,114	$ 5,276

GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Schedule of Long-Lived Assets by Geographic Region) (Details) - USD ($)
$ in Thousands

Jun. 30, 2015

Jun. 30, 2014

Long-lived assets by geographic region [Line Items]

Long-lived assets by geographic region [Line Items]

^[1]

$ 14,717

$ 5,351

Israel [Member]

Long-lived assets by geographic region [Line Items]

14,136

5,025

Europe [Member]

Long-lived assets by geographic region [Line Items]

230

211

U.S. [Member]

Long-lived assets by geographic region [Line Items]

342

112

Other [Member]